Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	antigen binding	IGHV1-69D IGHV7-81 IGHV1-69-2 IGHV1-38-4 IGHV1-69 IGHV1-58 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3 SLC7A5	6.32e-06	190	255	12	GO:0003823
GeneOntologyMolecularFunction	kainate selective glutamate receptor activity	GRIA2 GRIK1 GRIK2	4.00e-05	6	255	3	GO:0015277
GeneOntologyMolecularFunction	extracellularly glutamate-gated ion channel activity	GRIA2 GRIK1 GRIK2	6.94e-05	7	255	3	GO:0005234
GeneOntologyMolecularFunction	protein xylosyltransferase activity	XYLT1 XYLT2	1.62e-04	2	255	2	GO:0030158
GeneOntologyMolecularFunction	transmitter-gated channel activity	GABRQ GRIA2 GRID1 GRIK1 GRIK2 GABRA5	1.80e-04	65	255	6	GO:0022835
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity	GABRQ GRIA2 GRID1 GRIK1 GRIK2 GABRA5	1.80e-04	65	255	6	GO:0022824
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential	GRIA2 GRIK1 GRIK2 GABRA5	2.26e-04	24	255	4	GO:0099507
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	RALGAPA1 RAPGEF5 FRMD7 ALS2CL NRP1 DOCK5 IQSEC1 ARHGAP20 STXBP5L DOCK9 ARHGAP35 RASGRP1 SIPA1L1 ERRFI1 ARHGAP28 AGAP9 RASGRP2	2.98e-04	507	255	17	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	RALGAPA1 RAPGEF5 FRMD7 ALS2CL NRP1 DOCK5 IQSEC1 ARHGAP20 STXBP5L DOCK9 ARHGAP35 RASGRP1 SIPA1L1 ERRFI1 ARHGAP28 AGAP9 RASGRP2	2.98e-04	507	255	17	GO:0030695
GeneOntologyMolecularFunction	glutamate receptor activity	GRIA2 GRID1 GRIK1 GRIK2	3.62e-04	27	255	4	GO:0008066
GeneOntologyMolecularFunction	extracellular ligand-gated monoatomic ion channel activity	GABRQ GRIA2 GRID1 GRIK1 GRIK2 GABRA5	4.55e-04	77	255	6	GO:0005230
GeneOntologyMolecularFunction	tripeptidyl-peptidase activity	ACE TPP1	4.83e-04	3	255	2	GO:0008240
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	OPN4 OR5AK2 OR5B12 GABRQ OR14I1 NRP1 GPR146 GHSR OR1L6 ADGRF5 CCR4 CCR7 TACR3 PLXNA3 FLT3 UTS2R MCHR1 GALR3 GPR33 OR14J1 GRIA2 GRID1 GRIK1 GRIK2 OR8U3 CRHR2 OR10J5 CELSR3 TAS1R1 MRGPRX4 GABRA5 OR1L4	5.59e-04	1353	255	32	GO:0004888
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential	GRIA2 GRID1 GRIK1 GRIK2 GABRA5	7.96e-04	57	255	5	GO:1904315
GeneOntologyMolecularFunction	GTPase activator activity	RALGAPA1 ALS2CL NRP1 DOCK5 ARHGAP20 STXBP5L ARHGAP35 SIPA1L1 ERRFI1 ARHGAP28 AGAP9	9.65e-04	279	255	11	GO:0005096
GeneOntologyMolecularFunction	neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential	GRIA2 GRID1 GRIK1 GRIK2 GABRA5	1.01e-03	60	255	5	GO:0099529
GeneOntologyMolecularFunction	G protein-coupled receptor activity	OPN4 OR5AK2 OR5B12 OR14I1 GPR146 GHSR OR1L6 ADGRF5 CCR4 CCR7 TACR3 UTS2R MCHR1 GALR3 GPR33 OR14J1 OR8U3 CRHR2 OR10J5 CELSR3 TAS1R1 MRGPRX4 OR1L4	1.01e-03	884	255	23	GO:0004930
GeneOntologyMolecularFunction	glutamate-gated receptor activity	GRIA2 GRIK1 GRIK2	1.23e-03	17	255	3	GO:0004970
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	ATP6V1B1 ATP6V1B2 TMEM94 TRPC6 PKD1L1 GABRQ CLCN5 NALCN KCNJ3 SLC4A9 SLC6A18 CACNA1B CACNA1E GRIA2 GRID1 GRIK1 GRIK2 SLC9A5 KCNT2 SLC2A13 GABRA5	1.34e-03	793	255	21	GO:0015075
GeneOntologyMolecularFunction	ligand-gated sodium channel activity	GRIA2 GRIK1 GRIK2	1.46e-03	18	255	3	GO:0015280
GeneOntologyBiologicalProcess	behavior	ATP6V1B1 OPN4 BRINP1 ZZEF1 ACE BDNF GHSR PTCHD1 TACR3 MME DDHD2 CACNA1B CACNA1E UTS2R MCHR1 UBE2Q1 GALR3 ANKRD26 GRID1 GRIK1 GRIK2 NR1D1 CRHR2 USP2 UBA6 MRGPRX4 PCM1 GABRA5	4.47e-06	891	251	28	GO:0007610
GeneOntologyBiologicalProcess	immunoglobulin mediated immune response	IGHV1-69D C5 IGHV7-81 IGHV1-69-2 IGHV1-38-4 IGHV1-69 IGHV1-58 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3 RIF1	6.58e-06	235	251	13	GO:0016064
GeneOntologyBiologicalProcess	peptide catabolic process	ACE TPP1 MME ANPEP LNPEP	7.21e-06	23	251	5	GO:0043171
GeneOntologyBiologicalProcess	B cell mediated immunity	IGHV1-69D C5 IGHV7-81 IGHV1-69-2 IGHV1-38-4 IGHV1-69 IGHV1-58 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3 RIF1	9.86e-06	244	251	13	GO:0019724
GeneOntologyBiologicalProcess	neuropeptide catabolic process	ACE MME LNPEP	1.75e-05	5	251	3	GO:0010813
GeneOntologyCellularComponent	immunoglobulin complex	IGHV1-69D IGHV7-81 IGHV1-69-2 IGHV1-38-4 IGHV1-69 IGHV1-58 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3	6.17e-06	166	254	11	GO:0019814
GeneOntologyCellularComponent	presynapse	ATP6V1B1 ATP6V1B2 EXOC3 ZZEF1 BDNF SNAP29 CLCN5 KCNJ3 IQSEC1 TMEM163 MME ATG9A EPN1 CACNA1B CACNA1E VPS18 GRIA2 GRIK1 GRIK2 SRCIN1 CRHR2 CELSR3 SLC2A13 EXOC4 GABRA5	8.50e-05	886	254	25	GO:0098793
GeneOntologyCellularComponent	synaptic vesicle	ATP6V1B1 ATP6V1B2 BDNF SNAP29 CLCN5 IQSEC1 TMEM163 MME ATG9A GRIA2 SLC2A13 EXOC4	3.25e-04	300	254	12	GO:0008021
Domain	ARM-type_fold	RALGAPA1 CAND1 CUL9 ARMH1 DOCK5 PSME4 TAF2 HEATR5B ARMH3 DOCK9 HEATR5A FRYL RIF1 PRKDC TNPO3	3.33e-05	339	239	15	IPR016024
Domain	Lig_chan-Glu_bd	GRIA2 GRID1 GRIK1 GRIK2	6.95e-05	18	239	4	PF10613
Domain	Glu/Gly-bd	GRIA2 GRID1 GRIK1 GRIK2	6.95e-05	18	239	4	IPR019594
Domain	Lig_chan-Glu_bd	GRIA2 GRID1 GRIK1 GRIK2	6.95e-05	18	239	4	SM00918
Domain	Iontro_rcpt	GRIA2 GRID1 GRIK1 GRIK2	6.95e-05	18	239	4	IPR001320
Domain	Iono_rcpt_met	GRIA2 GRID1 GRIK1 GRIK2	6.95e-05	18	239	4	IPR001508
Domain	Lig_chan	GRIA2 GRID1 GRIK1 GRIK2	6.95e-05	18	239	4	PF00060
Domain	PBPe	GRIA2 GRID1 GRIK1 GRIK2	6.95e-05	18	239	4	SM00079
Domain	ANF_lig-bd_rcpt	GRIA2 GRID1 GRIK1 GRIK2 TAS1R1	1.03e-04	37	239	5	IPR001828
Domain	ANF_receptor	GRIA2 GRID1 GRIK1 GRIK2 TAS1R1	1.03e-04	37	239	5	PF01094
Domain	Peripla_BP_I	GRIA2 GRID1 GRIK1 GRIK2 TAS1R1	1.33e-04	39	239	5	IPR028082
Domain	XylT	XYLT1 XYLT2	1.63e-04	2	239	2	IPR024448
Domain	Xylo_C	XYLT1 XYLT2	1.63e-04	2	239	2	PF12529
Domain	V-ATPase_su_B/beta	ATP6V1B1 ATP6V1B2	1.63e-04	2	239	2	IPR022879
Domain	ATPase_V1-cplx_bsu	ATP6V1B1 ATP6V1B2	1.63e-04	2	239	2	IPR005723
Domain	Gamma_tubulin	TUBG2 TUBG1	1.63e-04	2	239	2	IPR002454
Domain	Peptidase_M1_N	TAF2 ANPEP LNPEP	5.38e-04	13	239	3	IPR014782
Domain	Peptidase_M1	TAF2 ANPEP LNPEP	5.38e-04	13	239	3	PF01433
Domain	-	CAND1 CUL9 ARMH1 PSME4 HEATR5B HEATR5A FRYL RIF1 PRKDC TNPO3	5.99e-04	222	239	10	1.25.10.10
Domain	ATPase_dyneun-rel_AAA	MDN1 DNAH5 DNAH8	6.79e-04	14	239	3	IPR011704
Domain	AAA_5	MDN1 DNAH5 DNAH8	6.79e-04	14	239	3	PF07728
Pubmed	Developmentally controlled and tissue-specific expression of unrearranged VH gene segments.	IGHV1-69D IGHV1-69-2 IGHV1-69 IGHV1-58 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-3	7.59e-17	9	259	8	2578321
Pubmed	Germline diversity of the expressed BALB/c VhJ558 gene family.	IGHV1-69D IGHV1-69-2 IGHV1-69 IGHV1-58 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-3	7.59e-17	9	259	8	11483206
Pubmed	Diversity of germ-line immunoglobulin VH genes.	IGHV1-69D IGHV1-69-2 IGHV1-69 IGHV1-58 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-3	7.59e-17	9	259	8	6789211
Pubmed	Combinatorial association of V genes: one VH gene codes for three non-cross-reactive monoclonal antibodies each specific for a different antigen (phoxazolone, NP or gat).	IGHV1-69D IGHV1-69-2 IGHV1-69 IGHV1-58 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-3	3.77e-16	10	259	8	3211160
Pubmed	Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a variable region.	IGHV1-69D IGHV1-69-2 IGHV1-69 IGHV1-58 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-3	3.48e-13	18	259	8	6788376
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TMEM94 CUL9 FHIP1B ZZEF1 CASZ1 TUBG1 MDN1 PSME4 NUAK1 ZFP36L2 TLN2 ATG9A PLXNA3 FLII DOCK9 GRID1 FRYL CLDN7 ARHGAP35 SBNO2 CELSR3 TRAPPC12 DUSP16 EHMT1 SLC7A5 ZFYVE26 IRS2 PRKDC TNPO3	5.06e-09	1105	259	29	35748872
Pubmed	IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.	IGHV1-69D IGHV1-69-2 IGHV1-69 IGHV1-58 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-3	1.15e-07	77	259	8	15608191
Pubmed	RNA editing of the glutamate receptor subunits GluR2 and GluR6 in human brain tissue.	GRIA2 GRIK1 GRIK2	4.08e-07	3	259	3	7523595
Pubmed	Ectopeptidases are differentially expressed in hepatocellular carcinomas.	ACE MME ANPEP	4.08e-07	3	259	3	14767532
Pubmed	Tlx1/3 and Ptf1a control the expression of distinct sets of transmitter and peptide receptor genes in the developing dorsal spinal cord.	GABRQ TACR3 GALR3 GRIA2 GRIK1 GRIK2 GABRA5	2.55e-06	81	259	7	22723691
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ATP6V1B2 CAND1 TM9SF3 ZMYM2 CASZ1 ZBTB7A MDN1 DDX50 ZFP36L2 SGPL1 TPP1 FBXO28 TAF2 HEATR5B EPN1 FHIP1A TFAP2D DSG2 MED16 XRCC1 INTS8 EPN2 CCNH RIF1 PBRM1 LNPEP SIPA1L1 EHMT1 SLC7A5	2.83e-06	1497	259	29	31527615
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	RALGAPA1 ATP6V1B2 MYH6 CAND1 DPYSL5 IGHV1-69D SGPL1 HECW2 IQSEC1 TLN2 GOLGA3 FLII VPS18 IGHV1-69-2 IGHV1-69 IGHV1-58 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-3 GRIA2 SRCIN1 ARHGAP35 EPN2 SIPA1L1 SSH2 PCM1 EXOC4	3.53e-06	1431	259	28	37142655
Pubmed	RNA editing in brain controls a determinant of ion flow in glutamate-gated channels.	GRIA2 GRIK1 GRIK2	4.04e-06	5	259	3	1717158
Pubmed	Novel Jbts17 mutant mouse model of Joubert syndrome with cilia transition zone defects and cerebellar and other ciliopathy related anomalies.	TUBG2 TUBG1 CPLANE1	4.04e-06	5	259	3	25877302
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ATP6V1B2 CAND1 PDE7A TUBG2 ZMYM2 CUL9 JAK1 MIA2 TPP1 TLN2 MIGA1 GOLGA3 FLII MCHR1 KIF21A EFEMP2 GRIK1 NR1D1 INTS8 USP2 RNF123 CELSR3 SIPA1L1 PRKDC PCM1 EXOC4	4.45e-06	1285	259	26	35914814
Pubmed	NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.	CAND1 MDN1 FRYL RFX1 RIF1 PBRM1 PRKDC CDC23	5.95e-06	129	259	8	23022380
Pubmed	Hereditary Spastic Paraplegia Overview	DDHD2 AMPD2 ATL1 ZFYVE26 BSCL2 SLC33A1	7.67e-06	63	259	6	20301682
Pubmed	The CPLANE protein Fuzzy regulates ciliogenesis by suppressing actin polymerization at the base of the primary cilium via p190A RhoGAP.	TUBG2 TUBG1 ARHGAP35	8.03e-06	6	259	3	38546045
Pubmed	Disruption of a ciliary B9 protein complex causes Meckel syndrome.	TUBG2 TUBG1 TMEM163 ISL2	8.47e-06	18	259	4	21763481
Pubmed	Association study of 182 candidate genes in anorexia nervosa.	GABRQ BDNF GHSR KCNJ3 MME GRIA2 CRHR2 TAS1R1 GABRA5	9.88e-06	182	259	9	20468064
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	FHIP1B DMXL1 SNAP29 ATG9A HEATR5B VPS18 DSG2 EPN2 TRAPPC12 LNPEP SLC7A5	1.09e-05	285	259	11	34369648
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	FHIP1B KIF21A SRCIN1 ARHGAP35 DUSP16 SSH2 EXOC4	1.18e-05	102	259	7	11214970
Pubmed	Telomere protection by TPP1/POT1 requires tethering to TIN2.	TINF2 TPP1 PRKDC	1.40e-05	7	259	3	22099311
Pubmed	Complete haplotype sequence of the human immunoglobulin heavy-chain variable, diversity, and joining genes and characterization of allelic and copy-number variation.	IGHV1-69D IGHV1-69-2 IGHV1-38-4	1.40e-05	7	259	3	23541343
Pubmed	Glutamate receptors in cortical plasticity: molecular and cellular biology.	GRIA2 GRIK1 GRIK2	1.40e-05	7	259	3	9016303
Pubmed	Drug target discovery by gene expression analysis: cell cycle genes.	CDCA4 CDCA7 CDC23	1.40e-05	7	259	3	12188893
Pubmed	Gene-environment interaction in the etiology of mathematical ability using SNP sets.	NUAK1 DNAH5 GRIK1	1.40e-05	7	259	3	20978832
Pubmed	Coexistence within one cell of microvillous and ciliary phototransductions across M1- through M6-IpRGCs.	OPN4 TRPC6 ADCY2	1.40e-05	7	259	3	38109525
Pubmed	Glutamate receptors: brain function and signal transduction.	GRIA2 GRIK1 GRIK2	1.40e-05	7	259	3	9651535
Pubmed	Primary structure and expression of the gamma 2 subunit of the glutamate receptor channel selective for kainate.	GRIA2 GRIK1 GRIK2	1.40e-05	7	259	3	1310861
Pubmed	Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.	GABRQ BDNF NRP1 SNAP29 GALR3 GRIA2 GRIK1 GRIK2 ARHGAP35 CRHR2 GABRA5	1.76e-05	300	259	11	19086053
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 CAND1 DPYSL5 ANKMY1 COG3 CASZ1 NRP1 SNAP29 DOCK5 TTC8 ZBTB7A KCNJ3 MME STXBP5L ABHD2 GRIK1 GRIK2 FRYL SRCIN1 ARHGAP35 INTS8 SBNO2 UBA6 EHMT1 BSCL2 PCM1 EXOC4	2.06e-05	1489	259	27	28611215
Pubmed	Chromosomal localization of glutamate receptor genes: relationship to familial amyotrophic lateral sclerosis and other neurological disorders of mice and humans.	MME GRIA2 GRIK1 GRIK2	2.38e-05	23	259	4	8464923
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	GPN1 DPYSL5 EXOC3 FBXO22 MDN1 COPS6 ARMH3 FLII DOCK9 SRCIN1 XIRP2 UBA6 IRS2 CDC23	2.51e-05	497	259	14	36774506
Pubmed	ICK is essential for cell type-specific ciliogenesis and the regulation of ciliary transport.	TUBG2 TUBG1 MCHR1 ISL2	2.84e-05	24	259	4	24797473
Pubmed	Patterned expression of ion channel genes in mouse dorsal raphe nucleus determined with the Allen Mouse Brain Atlas.	CLCN5 CACNA1B GRIK1 GRIK2	2.84e-05	24	259	4	22534482
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	RALGAPA1 COG3 DMXL1 SGPL1 MIGA1 ATG9A HEATR5B GOLGA3 VPS18 DSG2 ATL1 TRAPPC12 LNPEP SLC33A1	2.93e-05	504	259	14	34432599
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	CUL9 ZZEF1 TUBG1 JAK1 PSME4 GCLC HECW2 SIPA1L1 CDC23	3.31e-05	212	259	9	33853758
Pubmed	Splicing and editing of ionotropic glutamate receptors: a comprehensive analysis based on human RNA-Seq data.	GRID1 GRIK1 GRIK2	3.32e-05	9	259	3	34100982
Pubmed	Expression of glutamate receptor subunit genes during development of the mouse retina.	GRIA2 GRIK1 GRIK2	3.32e-05	9	259	3	9051806
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	CUL9 DNAH5 PLXNA3 ANPEP GRID1 RNF123 TRAPPC12 ERICH6B IRS2	3.56e-05	214	259	9	22199357
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CAND1 ZBTB22 ZMYM2 MDN1 IQSEC1 TLN2 GOLGA3 FERMT3 CACNA1E FLII AMPD2 KIF21A GRIA2 GRIK2 PBRM1 SIPA1L1 UBA6 EHMT1 SSH2 PCM1	4.10e-05	963	259	20	28671696
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	ATP6V1B1 GINM1 TM9SF3 COG3 ELOVL7 DOCK5 JAK1 MDN1 GCLC TMEM70 C5 ATG9A EPN1 TMPPE VPS18 INTS8 EPN2 RIF1 BSCL2 PRKDC SLC33A1	5.25e-05	1061	259	21	33845483
Pubmed	Endocytic recycling protein EHD1 regulates primary cilia morphogenesis and SHH signaling during neural tube development.	TUBG2 TUBG1 SNAP29 EPN1	5.35e-05	28	259	4	26884322
Pubmed	CCR4 and CCR7 differentially regulate thymocyte localization with distinct outcomes for central tolerance.	CCR4 CCR7	5.52e-05	2	259	2	37266571
Pubmed	Changes in V-ATPase subunits of human urinary exosomes reflect the renal response to acute acid/alkali loading and the defects in distal renal tubular acidosis.	ATP6V1B1 ATP6V1B2	5.52e-05	2	259	2	29310826
Pubmed	Divergent iron regulatory states contribute to heterogeneity in breast cancer aggressiveness.	C5 PRKDC	5.52e-05	2	259	2	39262774
Pubmed	Serum xylosyltransferase: a new biochemical marker of the sclerotic process in systemic sclerosis.	XYLT1 XYLT2	5.52e-05	2	259	2	10383739
Pubmed	Modulation of excitatory synaptic transmission in the spinal substantia gelatinosa of mice deficient in the kainate receptor GluR5 and/or GluR6 subunit.	GRIK1 GRIK2	5.52e-05	2	259	2	14724198
Pubmed	Desmoglein 2 mutant mice develop cardiac fibrosis and dilation.	TMEM163 DSG2	5.52e-05	2	259	2	21455723
Pubmed	High xylosyltransferase activity in children and during mineralization of osteoblast-like SAOS-2 cells.	XYLT1 XYLT2	5.52e-05	2	259	2	18763033
Pubmed	Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II.	XYLT1 XYLT2	5.52e-05	2	259	2	11099377
Pubmed	The kainate receptor subunit GluR6 mediates metabotropic regulation of the slow and medium AHP currents in mouse hippocampal neurones.	GRIK1 GRIK2	5.52e-05	2	259	2	15539395
Pubmed	Fast-evolving cofactors regulate the role of HEATR5 complexes in intra-Golgi trafficking.	HEATR5B HEATR5A	5.52e-05	2	259	2	38240799
Pubmed	Xylosyltransferase gene variants and their role in essential hypertension.	XYLT1 XYLT2	5.52e-05	2	259	2	19197251
Pubmed	Association between polymorphisms in DNA repair genes (XRCC1 and XRCC7) and risk of preeclampsia.	XRCC1 PRKDC	5.52e-05	2	259	2	22825692
Pubmed	Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6.	GRIK1 GRIK2	5.52e-05	2	259	2	8260617
Pubmed	MTOC reorientation occurs during FcgammaR-mediated phagocytosis in macrophages.	TUBG2 TUBG1	5.52e-05	2	259	2	17442887
Pubmed	Incompatibility in cell adhesion constitutes a barrier to interspecies chimerism.	C5 PRKDC	5.52e-05	2	259	2	39181131
Pubmed	Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses.	GRIK1 GRIK2	5.52e-05	2	259	2	15537878
Pubmed	Development of a xylosyltransferase-I-selective UPLC MS/MS activity assay using a specific acceptor peptide.	XYLT1 XYLT2	5.52e-05	2	259	2	33609631
Pubmed	Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: an effective bradykinin inactivation pathway.	ACE MME	5.52e-05	2	259	2	21651905
Pubmed	Postnatal maturation of mossy fibre excitatory transmission in mouse CA3 pyramidal cells: a potential role for kainate receptors.	GRIK1 GRIK2	5.52e-05	2	259	2	15358807
Pubmed	Human xylosyltransferase II is involved in the biosynthesis of the uniform tetrasaccharide linkage region in chondroitin sulfate and heparan sulfate proteoglycans.	XYLT1 XYLT2	5.52e-05	2	259	2	17189265
Pubmed	Biosynthesis of chondroitin and heparan sulfate in chinese hamster ovary cells depends on xylosyltransferase II.	XYLT1 XYLT2	5.52e-05	2	259	2	17189266
Pubmed	Allocation of gamma-tubulin between oocyte cortex and meiotic spindle influences asymmetric cytokinesis in the mouse oocyte.	TUBG2 TUBG1	5.52e-05	2	259	2	17287496
Pubmed	The role of LNPEP and ANPEP gene polymorphisms in the pathogenesis of pre-eclampsia.	ANPEP LNPEP	5.52e-05	2	259	2	32619880
Pubmed	Identification of the kainate receptor subunits underlying modulation of excitatory synaptic transmission in the CA3 region of the hippocampus.	GRIK1 GRIK2	5.52e-05	2	259	2	11069933
Pubmed	Presynaptic kainate receptors impart an associative property to hippocampal mossy fiber long-term potentiation.	GRIK1 GRIK2	5.52e-05	2	259	2	12947409
Pubmed	Differential expression of human γ-tubulin isotypes during neuronal development and oxidative stress points to a γ-tubulin-2 prosurvival function.	TUBG2 TUBG1	5.52e-05	2	259	2	28119396
Pubmed	[Glutamate receptors genes polymorphism and the risk of paranoid schizophrenia in Russians and tatars from the Republic of Bashkortostan].	GRIA2 GRIK2	5.52e-05	2	259	2	25842862
Pubmed	Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma.	C5 PRKDC	5.52e-05	2	259	2	37057874
Pubmed	Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences.	GRIK1 GRIK2	5.52e-05	2	259	2	8700852
Pubmed	Q/R site editing controls kainate receptor inhibition by membrane fatty acids.	GRIK1 GRIK2	5.52e-05	2	259	2	16221857
Pubmed	Subunit composition and alternative splicing regulate membrane delivery of kainate receptors.	GRIK1 GRIK2	5.52e-05	2	259	2	15014126
Pubmed	Upregulation of Phosphodiesterase 7A Contributes to Concurrent Pain and Depression via Inhibition of cAMP-PKA-CREB-BDNF Signaling and Neuroinflammation in the Hippocampus of Mice.	PDE7A BDNF	5.52e-05	2	259	2	39283715
Pubmed	Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.	ACE MME	5.52e-05	2	259	2	27096746
Pubmed	Transcriptomic Signatures of Postnatal and Adult Intrinsically Photosensitive Ganglion Cells.	OPN4 RASGRP1	5.52e-05	2	259	2	31387875
Pubmed	Functional characterization of kainate receptors in the mouse nucleus accumbens.	GRIK1 GRIK2	5.52e-05	2	259	2	11985817
Pubmed	XRCC1 is phosphorylated by DNA-dependent protein kinase in response to DNA damage.	XRCC1 PRKDC	5.52e-05	2	259	2	16397295
Pubmed	Xylosyltransferase activity in seminal plasma of infertile men.	XYLT1 XYLT2	5.52e-05	2	259	2	11814476
Pubmed	Gene knockout analysis of two gamma-tubulin isoforms in mice.	TUBG2 TUBG1	5.52e-05	2	259	2	15893303
Pubmed	Heterogeneity of vacuolar H(+)-ATPase: differential expression of two human subunit B isoforms.	ATP6V1B1 ATP6V1B2	5.52e-05	2	259	2	7945239
Pubmed	Upregulating sirtuin 6 ameliorates glycolysis, EMT and distant metastasis of pancreatic adenocarcinoma with krüppel-like factor 10 deficiency.	C5 PRKDC	5.52e-05	2	259	2	34702956
Pubmed	Altered behavioral responses to noxious stimuli and fear in glutamate receptor 5 (GluR5)- or GluR6-deficient mice.	GRIK1 GRIK2	5.52e-05	2	259	2	15673679
Pubmed	Relocalization of the V-ATPase B2 subunit to the apical membrane of epididymal clear cells of mice deficient in the B1 subunit.	ATP6V1B1 ATP6V1B2	5.52e-05	2	259	2	17392376
Pubmed	CD13 and CD10 expression of granulocytes as markers for the functioning of the immune system: quantification of the expression of membrane molecules using 1:1 labeled monoclonal antibodies and flow cytometry.	MME ANPEP	5.52e-05	2	259	2	18605079
Pubmed	Blocking the R-type (Cav2.3) Ca2+ channel enhanced morphine analgesia and reduced morphine tolerance.	CACNA1B CACNA1E	5.52e-05	2	259	2	15610184
Pubmed	Kainate receptors are involved in short- and long-term plasticity at mossy fiber synapses in the hippocampus.	GRIK1 GRIK2	5.52e-05	2	259	2	11182092
Pubmed	Expression of xylosyltransferases I and II and their role in the pathogenesis of arthrofibrosis.	XYLT1 XYLT2	5.52e-05	2	259	2	31973761
Pubmed	Mammalian exocyst complex is required for the docking step of insulin vesicle exocytosis.	EXOC3 EXOC4	5.52e-05	2	259	2	15878854
Pubmed	Differential requirement for CCR4 and CCR7 during the development of innate and adaptive αβT cells in the adult thymus.	CCR4 CCR7	5.52e-05	2	259	2	24990081
Pubmed	Compensatory membrane expression of the V-ATPase B2 subunit isoform in renal medullary intercalated cells of B1-deficient mice.	ATP6V1B1 ATP6V1B2	5.52e-05	2	259	2	17898041
Pubmed	RNA editing of human kainate receptor subunits.	GRIK1 GRIK2	5.52e-05	2	259	2	7696618
Pubmed	High-copy suppressor analysis reveals a physical interaction between Sec34p and Sec35p, a protein implicated in vesicle docking.	COG3 GOLGA3	5.52e-05	2	259	2	10512869
Pubmed	Isolation of slow-cycling cancer cells from lung patient-derived xenograft using carboxyfluorescein-succinimidyl ester retention-mediated cell sorting.	C5 PRKDC	5.52e-05	2	259	2	36924504
Pubmed	Overexpression of γ-tubulin in non-small cell lung cancer.	TUBG2 TUBG1	5.52e-05	2	259	2	22806905
Pubmed	Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models.	C5 PRKDC	5.52e-05	2	259	2	39047119
Pubmed	Curvature of clathrin-coated pits driven by epsin.	EPN1 EPN2	5.52e-05	2	259	2	12353027
Pubmed	Sec6/8 regulates Bcl-2 and Mcl-1, but not Bcl-xl, in malignant peripheral nerve sheath tumor cells.	EXOC3 EXOC4	5.52e-05	2	259	2	26892009
Interaction	GPR17 interactions	EXOC3 COG3 FHIP1B XYLT2 MDN1 MIGA1 HEATR5B TMPPE UBE2Q1 HEATR5A RIF1 PRKDC SLC33A1 TNPO3 CDC23 EXOC4	3.49e-07	283	242	16	int:GPR17
Cytoband	14q32.33	IGHV7-81 CDCA4 IGHV1-69-2 IGHV1-38-4 IGHV1-69 IGHV1-58 IGHV1-46 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3 IGHV1-2	7.55e-10	228	259	13	14q32.33
Cytoband	Ensembl 112 genes in cytogenetic band chr14q32	IGHV1-69D IGHV7-81 CDCA4 IGHV1-69-2 IGHV1-69 IGHV1-58 IGHV1-46 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-3 IGHV1-2	1.03e-04	566	259	12	chr14q32
Cytoband	14q12	MYH6 TINF2 GPR33 HEATR5A	2.69e-04	55	259	4	14q12
Cytoband	13q14.13	COG3 LRRC63 ERICH6B	2.89e-04	23	259	3	13q14.13
GeneFamily	Immunoglobulin heavy locus at 14q32.33	IGHV1-69D IGHV7-81 IGHV1-69-2 IGHV1-38-4 IGHV1-69 IGHV1-58 IGHV1-46 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3 IGHV1-2	6.72e-08	187	185	13	349
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3	IGHV1-69D IGHV1-69-2 IGHV1-69 IGHV1-58 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-3	6.13e-11	25	252	8	MM870
Coexpression	RASHI_RESPONSE_TO_IONIZING_RADIATION_6	PDE7A IGHV1-69D TMEM70 FERMT3 IGHV1-69-2 IGHV1-69 IGHV1-58 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-3	6.48e-08	132	252	11	MM996
Coexpression	MIKKELSEN_NPC_HCP_WITH_H3K27ME3	BNC2 TRPC6 GHSR ST8SIA6 COL14A1 TMEM163 FLT3 TFAP2D GALR3 SGPP2 GSX2 SRCIN1 CLDN7 GABRA5	7.13e-06	345	252	14	M2009
Coexpression	MIKKELSEN_NPC_HCP_WITH_H3K27ME3	BNC2 TRPC6 GHSR ST8SIA6 COL14A1 TMEM163 FLT3 TFAP2D GALR3 SGPP2 GSX2 SRCIN1 CLDN7 GABRA5	7.61e-06	347	252	14	MM860
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	RALGAPA1 TMEM94 XYLT2 PRDM10 ZFP36L2 PRR14L FRYL RIF1 SIPA1L1 PCM1	1.03e-05	180	252	10	M8239
Coexpression	GSE22886_NAIVE_TCELL_VS_NKCELL_DN	ZCCHC24 TIPRL ADCY2 SNAP29 PRDM10 PSME4 WIPI1 ABHD2 FRYL UEVLD	2.36e-05	198	252	10	M4415
Coexpression	RASHI_RESPONSE_TO_IONIZING_RADIATION_6	PDE7A TMEM70 FERMT3 IGHV1-58 IGHV1-46 IGHV1-45 IGHV1-18	4.30e-05	97	252	7	M1560
Coexpression	GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP	ALS2CL GPR146 CCR4 CCR7 MME RASGRP1 SIPA1L1 ARHGAP28 IRS2	4.38e-05	171	252	9	M6316
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	BNC2 PDE7A NRP1 PKHD1 ANKRD26 SIPA1L1 ERRFI1 SSH2 EXOC4	5.48e-05	176	252	9	M39223
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	BNC2 PDE7A NRP1 PKHD1 TLN2 MME ANKRD26 SIPA1L1 ERRFI1 EXOC4	5.98e-05	221	252	10	M39222
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3	IGHV1-58 IGHV1-46 IGHV1-45 IGHV1-18	6.40e-05	23	252	4	M12322
Coexpression	BCAT_BILD_ET_AL_DN	GRID1 FRYL RIF1 LNPEP PRKDC	7.84e-05	46	252	5	M2702
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDE7A ESRP1 BCAT1 SCEL PKHD1 C5 DNAH5 KIF21A HEATR5A CLDN7 ERRFI1	2.28e-08	197	258	11	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH6 PSME4 KCNJ3 COL14A1 GOLGA3 ECM2 KCNT2 XIRP2 LNPEP PCM1	8.50e-08	176	258	10	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC6 ALS2CL DOCK5 NALCN TMEM163 MME GRIK2 ITIH5 KCNT2 ARHGAP28	1.22e-07	183	258	10	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE7A ESRP1 BCAT1 SCEL PKHD1 C5 FHIP1A KIF21A SGPP2 ERRFI1	1.43e-07	186	258	10	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 SCEL PKHD1 C5 FHIP1A DSG2 KIF21A SGPP2 ERRFI1	1.50e-07	187	258	10	ff26a533d310126521efe1d05cf8b9d32e524550
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	RALGAPA1 CAND1 MIGA1 CPLANE1 ZBTB33 KIF21A HEATR5A FRYL PBRM1 PRKDC	2.01e-07	193	258	10	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY2 MOV10L1 PKHD1 MME CACNA1B LAMA2 GRIK2 CRB1 KCNT2	4.14e-07	160	258	9	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY2 MOV10L1 PKHD1 MME CACNA1B LAMA2 GRIK2 CRB1 KCNT2	4.14e-07	160	258	9	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESRP1 ANKMY1 ACE SLC22A7 MME SLC6A18 DOCK9 ITIH5 TAS1R1	5.93e-07	167	258	9	40d102e01ccbc7262d00fafd59ca5234909009cb
ToppCell	COVID-19_Mild-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	RAPGEF5 PKD1L1 ESRP1 BRINP1 CCDC168 MIA2 NUAK1 MIGA1	6.51e-07	124	258	8	5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4
ToppCell	droplet-Kidney-nan-3m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESRP1 ANKMY1 ACE SLC22A7 MME SLC6A18 DOCK9 ITIH5 TAS1R1	6.89e-07	170	258	9	dd48fd3c5c67eb71183981f42975a538f12077c3
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 MME FHIP1A KIF21A SGPP2 ERRFI1	1.11e-06	180	258	9	b798a3fa2dd15b68aa4267f665559527043dcc07
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGB7 IGHV1-69D IGHV1-69 IGHV1-58 IGHV1-46 IGHV1-24 IGHV1-18 IGHV1-2 ERICH6B	1.11e-06	180	258	9	cea079bc02e08c46600eed05ab9924ec90e1e3d3
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA13 RAPGEF5 SCEL TMEM163 ADGRF5 FHIP1A DOCK9 SGPP2 EPN2	1.16e-06	181	258	9	576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell	Control-Epithelial_alveolar-AT_1-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 SCEL PKHD1 C5 MME DSG2 KIF21A ERRFI1	1.22e-06	182	258	9	a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 MME FHIP1A KIF21A SGPP2 ERRFI1	1.22e-06	182	258	9	1e2149b222a3e9f64841aed45288a6f29394e7b0
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 MME FHIP1A KIF21A SGPP2 CLDN7	1.22e-06	182	258	9	d1a1feef318062f25493355d7beee8e5fb0e4206
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PTCHD1 NALCN COL14A1 ADGRF5 ECM2 LAMA2 GRID1 KCNT2 RASGRP2	1.27e-06	183	258	9	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC6 ALS2CL DOCK5 NALCN TACR3 GRIK2 ITIH5 KCNT2 ARHGAP28	1.27e-06	183	258	9	7c4b775f351794a3de06bd503eecbc8ae8577c44
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 MME FHIP1A KIF21A SGPP2 ERRFI1	1.33e-06	184	258	9	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 SCEL PKHD1 C5 FHIP1A DSG2 KIF21A ERRFI1	1.39e-06	185	258	9	3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC22A7 PRODH2 PKHD1 TLN2 MME CACNA1E ANPEP USP2 ERRFI1	1.46e-06	186	258	9	5784d255e9ca449d375d81938d0fbbd8a7eb44f6
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ATP6V1B1 FRMD7 ST8SIA6 ADGRF5 SLC4A9 DSG2 ABHD2 KIF21A ITIH5	1.52e-06	187	258	9	7b0168bdaa7c6c6b39878aff6a17f0943189a380
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 FHIP1A KIF21A SGPP2 ERRFI1 IRS2	1.59e-06	188	258	9	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADCY2 BDNF PTCHD1 NALCN ECM2 LAMA2 GRIA2 KCNT2 ARHGAP28	1.74e-06	190	258	9	2e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADCY2 BDNF PTCHD1 NALCN ECM2 LAMA2 GRIA2 KCNT2 ARHGAP28	1.74e-06	190	258	9	0028f886c789ba238c031eae5d96acaed4af8c25
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RAPGEF5 ACE CASZ1 GPR146 ST8SIA6 HECW2 ADGRF5 DOCK9 GRID1	1.81e-06	191	258	9	1de0bdfd13bd930691564c2673f2e66393bc0255
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACE ELOVL7 ST8SIA6 HECW2 ADGRF5 DOCK9 SGPP2 ITIH5 SLC7A5	2.06e-06	194	258	9	cceb7c88492bb6cd531e1c2651638da1ddf30931
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ACE ELOVL7 ST8SIA6 HECW2 ADGRF5 DOCK9 SGPP2 ITIH5 SLC7A5	2.06e-06	194	258	9	ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CCR7 ALAS2 IGHV1-69 IGHV1-58 IGHV1-45 IGHV1-24 IGHV1-18 IGHV1-2 RASGRP2	2.06e-06	194	258	9	a4a70369541876e1192df8828b63e3d1746ae3d9
ToppCell	LPS-IL1RA-Epithelial_alveolar-Mes-Like-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DPYSL5 ADCY2 BDNF HECW2 DNAH5 DNAH8 EXOC4	2.33e-06	103	258	7	eb9f008b5fb8a01df8ea4faf6e6aebc1a9db9bd3
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RAPGEF5 ACE NRP1 GPR146 ST8SIA6 HECW2 ADGRF5 DOCK9 FRYL	2.44e-06	198	258	9	d5990cab01de6e6f3757f5a50ef70ced711bb1fa
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPC6 COL14A1 ADGRF5 MOCS1 GRID1 CRHR2 KCNT2 ARHGAP28 RASGRP2	2.44e-06	198	258	9	b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 CABYR C5 FHIP1A KIF21A SGPP2 ERRFI1	3.17e-06	153	258	8	e7a074ea8232bacf924be78a244a8507c7e1ebc8
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tregs\|GI_small-bowel / Manually curated celltypes from each tissue	ALS2CL PKHD1 CCR4 CCR7 DNAH8 SGPP2 RASGRP1 DUSP16	3.49e-06	155	258	8	d4ef25965a15eab7679478b9b661e1b4a92f1c59
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC6 CCDC168 ALS2CL NALCN MME ANPEP GRIK2 ARHGAP28	4.22e-06	159	258	8	fd7db2f7328cfefdc3ada2af91006d5a91d137e1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC6 CCDC168 ALS2CL NALCN MME ANPEP GRIK2 ARHGAP28	4.22e-06	159	258	8	aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC6 CCDC168 ALS2CL NALCN MME ANPEP GRIK2 ARHGAP28	4.22e-06	159	258	8	8bbdef1e927f3130b578d7d7c5ff38bbe06fab63
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADCY2 NALCN KCNJ3 CACNA1B STXBP5L GRIA2 GRIK2 POTEJ	5.30e-06	164	258	8	be49af6335f2505065cde2cb9800e4a5516811b1
ToppCell	LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LCN12 SCEL ADCY2 PTCHD1 PKHD1 MOCS1 TFAP2D	5.45e-06	117	258	7	f3c77b234e461566aac81ede0ef84008c9a9f51e
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	BNC2 TRPC6 DPYSL5 GHSR TACR3 CACNA1E TMEM232 XIRP2	5.79e-06	166	258	8	6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADCY2 KCNJ3 CACNA1B CACNA1E STXBP5L GRIA2 GRIK2 POTEJ	6.61e-06	169	258	8	b6b5bb6408c1305a00719e1b88a5e1202081faf3
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RAPGEF5 TRPC6 BDNF NRP1 NUAK1 ADGRF5 ECM2 RASGRP2	7.20e-06	171	258	8	285533ca2a6a411773313166bee35542f34d1a3c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 PDE7A SLC22A7 PRODH2 MME CACNA1E ANPEP ERRFI1	7.84e-06	173	258	8	8888434641ea554a9b62c436e87920378eef29cd
ToppCell	PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABCA13 PKD1L1 ESRP1 BRINP1 PTCHD1 MIA2 COL17A1	8.88e-06	126	258	7	69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb
ToppCell	PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ABCA13 PKD1L1 ESRP1 BRINP1 PTCHD1 MIA2 COL17A1	8.88e-06	126	258	7	6cb89754010d64875e115da6c5805efac7a4a82d
ToppCell	droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCAT1 SCEL ALS2CL SLC35G1 LAMA2 HEATR5A ATL1 ARHGAP28	8.90e-06	176	258	8	533d544852038c0612aacf87f4b1c88ff7aace82
ToppCell	-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	ITGB7 IGHV1-69-2 IGHV1-69 IGHV1-46 IGHV1-24 IGHV1-18 IGHV1-2 CDCA7	9.27e-06	177	258	8	ae2d2e138946535596fa30a55207f261cafda461
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC6 ALS2CL DOCK5 NALCN MME GRIK2 KCNT2 ARHGAP28	1.01e-05	179	258	8	7394e77e665bf16d3733df91bb12907be460ab44
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 FHIP1A KIF21A SGPP2 ERRFI1	1.01e-05	179	258	8	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 TTC8 NUAK1 COL14A1 ARHGAP20 ECM2 GRID1 ITIH5	1.05e-05	180	258	8	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 TTC8 NUAK1 COL14A1 ARHGAP20 ECM2 GRID1 ITIH5	1.05e-05	180	258	8	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 FHIP1A KIF21A SGPP2 ERRFI1	1.09e-05	181	258	8	0513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 PDE7A SLC22A7 NRP1 PRODH2 MME ANPEP ERRFI1	1.09e-05	181	258	8	9542c19edc9bd2cba68c01c2a8407705398e3011
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC6 ALS2CL DOCK5 NALCN MME GRIK2 XIRP2 ARHGAP28	1.09e-05	181	258	8	5bf7aa43f6e6ecce15c95928b91195544d6928c4
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 PDE7A SLC22A7 NRP1 PRODH2 MME ANPEP ERRFI1	1.09e-05	181	258	8	8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC6 ALS2CL DOCK5 NALCN MME GRIK2 XIRP2 ARHGAP28	1.09e-05	181	258	8	8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9
ToppCell	Epithelial-lung_neuroendocrine_cell_(PNEC)\|World / Lineage, Cell type, age group and donor	ADCY2 NALCN KCNJ3 CACNA1B STXBP5L GRIA2 GRIK2 POTEJ	1.14e-05	182	258	8	57bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 FHIP1A KIF21A SGPP2 ERRFI1	1.14e-05	182	258	8	17ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC6 ALS2CL DOCK5 TACR3 MME GRIK2 ITIH5 ARHGAP28	1.18e-05	183	258	8	eb559ae3ae252d9365c24ef557dd49b78ed6d898
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 C5 FHIP1A DSG2 KIF21A CLDN7 ERRFI1	1.18e-05	183	258	8	06ac66726ec53db810ebb90ec69cfdb903da53f6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC6 ALS2CL DOCK5 TACR3 MME GRIK2 ITIH5 ARHGAP28	1.18e-05	183	258	8	612d93df03252d4d2ccdce5a9bc162cfd9172a1a
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 SCEL PKHD1 C5 FHIP1A KIF21A ERRFI1	1.18e-05	183	258	8	ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 FHIP1A KIF21A SGPP2 ERRFI1	1.18e-05	183	258	8	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 MME FHIP1A KIF21A ERRFI1	1.23e-05	184	258	8	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 FHIP1A KIF21A SGPP2 ERRFI1	1.23e-05	184	258	8	d0c212a8fbaad24597a84018442b25c61c17ea58
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC6 ALS2CL CASZ1 DOCK5 MME GRIK2 ITIH5 ARHGAP28	1.23e-05	184	258	8	7294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCell	Control-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 MME FHIP1A KIF21A ERRFI1	1.28e-05	185	258	8	0d2add28ac1f4fa6de7699be009bf8391badaf4c
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 FHIP1A KIF21A SGPP2 ERRFI1	1.28e-05	185	258	8	fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 SCEL PKHD1 C5 FHIP1A KIF21A ERRFI1	1.28e-05	185	258	8	3937e026add96a396122139daf8011cfbc60e75c
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 FHIP1A DSG2 KIF21A SGPP2	1.28e-05	185	258	8	68f428e169cfb77de970bdfdeea9b9f16f68d2ba
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EFS FRMD7 ARMH1 COL14A1 ANPEP ECM2 LAMA2 ITIH5	1.28e-05	185	258	8	1b990e3089772be2b38c6d7ea0d1bf22461ae3ea
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 SCEL PKHD1 FHIP1A DSG2 KIF21A SGPP2	1.28e-05	185	258	8	0c247a3f394c42e2a6f67fee3d9cf33096fecd13
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ELOVL7 KCNJ3 LCN15 TMEM163 STXBP5L SGPP2 GRIA2 GRIK2	1.33e-05	186	258	8	c7983281a290201567b398e9ea6baddb96c692bb
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ESRP1 CASZ1 ST8SIA6 TMEM163 ADGRF5 SLC4A9 DSG2 ITIH5	1.33e-05	186	258	8	a6ef5d5944af5689b5f27bef89cd05645eedbe50
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 FHIP1A KIF21A SGPP2 ERRFI1	1.33e-05	186	258	8	e0a2ea4b46af742bc7c9b2072bb85e27d5c92712
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 FHIP1A KIF21A SGPP2 ERRFI1	1.33e-05	186	258	8	e83718fabb057100835d3357df407f283d23fe16
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 TMEM163 C5 FHIP1A KIF21A SGPP2 ERRFI1	1.38e-05	187	258	8	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NALCN KCNJ3 TMEM163 CACNA1E STXBP5L GRIA2 GRIK2 POTEJ	1.38e-05	187	258	8	98477ba04a42a8da80a72f41a182429f46283595
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	ABCA13 TMEM163 ADGRF5 C5 DNAH5 DOCK9 SGPP2 DUSP16	1.44e-05	188	258	8	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ESRP1 SCEL CASZ1 TMEM163 ADGRF5 DNAH5 FHIP1A SGPP2	1.44e-05	188	258	8	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ESRP1 CASZ1 ST8SIA6 TMEM163 ADGRF5 SLC4A9 DSG2 ITIH5	1.44e-05	188	258	8	e751cff2ac8fbc1487766c1871fcc5d1005286b0
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	SCEL DOCK5 TMEM163 ADGRF5 DNAH5 FHIP1A SGPP2 ERRFI1	1.44e-05	188	258	8	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	Control-B_memory-6\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	BCAT1 SCEL DNAH8 CACNA1B RASGRP1 CDCA7 DUSP16	1.46e-05	136	258	7	94f23bef50c0beb54ed39b1a4b340f7aec4e75cd
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ESRP1 BCAT1 SCEL C5 FHIP1A KIF21A SGPP2 ERRFI1	1.49e-05	189	258	8	5f883ef4cc0383142d538ae61f4fb40dfdb8ef18
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RAPGEF5 NRP1 ST8SIA6 NUAK1 HECW2 ADGRF5 LDLRAD4 DOCK9	1.49e-05	189	258	8	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV1-69D IGHV1-69-2 IGHV1-69 IGHV1-46 IGHV1-24 IGHV1-18 IGHV1-3 IGHV1-2	1.55e-05	190	258	8	79ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV1-69D IGHV1-69-2 IGHV1-69 IGHV1-46 IGHV1-24 IGHV1-18 IGHV1-3 IGHV1-2	1.55e-05	190	258	8	18762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NRP1 XYLT1 NALCN COL14A1 ARHGAP20 ECM2 LAMA2 KCNT2	1.61e-05	191	258	8	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ESRP1 PKHD1 TMEM163 ADGRF5 C5 FHIP1A DOCK9 ERRFI1	1.61e-05	191	258	8	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	PCW_05-06-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RAPGEF5 ACE ST8SIA6 LCN15 ADGRF5 DOCK9 GRIA2 RASGRP2	1.61e-05	191	258	8	e3fc5c92491b6e334abffbf085c00a0b5fa1aed2
ToppCell	5'-Adult-LargeIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGB7 IGHV1-69D IGHV1-69-2 IGHV1-46 IGHV1-18 IGHV1-3 IGHV1-2 SLC7A5	1.61e-05	191	258	8	d1d30279ed4612b4f62c225d9eabf0b8a7a09d11
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TLN2 MME ARHGAP20 LAMA2 ITIH5 ERRFI1 IRS2 PCM1	1.61e-05	191	258	8	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NRP1 XYLT1 NALCN COL14A1 ARHGAP20 ECM2 LAMA2 KCNT2	1.61e-05	191	258	8	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	BNC2 RAPGEF5 ST8SIA6 MOV10L1 MCHR1 DOCK9 KCNT2 SIPA1L1	1.67e-05	192	258	8	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	COPD-Myeloid-cDC2\|Myeloid / Disease state, Lineage and Cell class	XYLT1 TMEM163 FHIP1A LDLRAD4 FLT3 TMEM232 SIPA1L1 SLC7A5	1.67e-05	192	258	8	984cdc2f1d93e164bc946d63f58dacb629f82eb7
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RAPGEF5 TRPC6 NALCN ECM2 GRID1 ITIH5 KCNT2 RASGRP2	1.67e-05	192	258	8	24e2f15f5767a97eb3b389922bcfd7b13805e1ce
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZCCHC24 EFS ACE COL14A1 ARHGAP20 ECM2 LAMA2 ITIH5	1.67e-05	192	258	8	e4a7f2673f801b008ca67291db2fb2b9fd2955b8
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACE COL14A1 MME ANPEP ECM2 EFEMP2 LAMA2 ITIH5	1.67e-05	192	258	8	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZCCHC24 EFS ACE COL14A1 ARHGAP20 ECM2 LAMA2 ITIH5	1.67e-05	192	258	8	8937a59f6bbe07f671bdabbd3707dc9c17a14cd9
Drug	EN-1530	GABRQ EPX ADCY2 KCNJ3 TACR3 MME FLII UTS2R GRIA2 GRIK1 GRIK2 CRHR2 IKZF4 GABRA5	2.43e-06	278	248	14	CID000004425
Drug	gabapentin	GABRQ BCAT1 CACNA1B CACNA1E ANPEP GRIA2 GRID1 GRIK1 SLC7A5 SLC2A13 GABRA5	2.61e-06	169	248	11	CID000003446
Drug	D-N-Q	GABRQ BDNF SGPL1 FLII GRIA2 GRIK1 GRIK2 GABRA5	3.78e-06	84	248	8	CID000003140
Drug	haloperidol	GABRQ ADCY2 BDNF TACR3 MME CACNA1B CACNA1E FLII MCHR1 ANPEP ABCB5 GRIA2 GRID1 GRIK1 GRIK2 GABRA5	7.43e-06	394	248	16	CID000003559
Drug	Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A	SCEL ZZEF1 ITGB7 ZBTB7A ADGRF5 CCR4 CCR7 GALR3 DUOX2 GRIK2 RASGRP2	1.08e-05	196	248	11	6715_UP
Drug	Ioversol [87771-40-2]; Up 200; 5uM; HL60; HT_HG-U133A	EPX ZZEF1 SLC22A7 BDNF KCNJ3 IQSEC1 COL17A1 GALR3 LAMA2 CRB1 GABRA5	1.13e-05	197	248	11	3026_UP
Drug	biotinyl-L-lysine	GABRQ EPX TACR3 GRIA2 MARCHF7 GRIK1 CRHR2 GABRA5	1.29e-05	99	248	8	CID000083814
Drug	avermectin	VPS18 ABCB5 GRIA2 GRID1 GRIK1 UEVLD	1.32e-05	48	248	6	CID006450460
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NRP1 PRDM10 NUAK1 ZFP36L2 SGPL1 KCNJ3 SMG9 ARHGAP35 SBNO2 RASGRP1	1.40e-05	165	248	10	6085_DN
Drug	LY354740	BDNF KCNJ3 GRIA2 GRID1 GRIK1 GRIK2	1.88e-05	51	248	6	CID000114827
Drug	DNQX	GABRQ BDNF FLII GRIA2 GRID1 GRIK1 GABRA5	3.43e-05	83	248	7	CID003899541
Drug	XeC compound	TRPC6 BDNF GHSR CACNA1B CACNA1E GRIK1 EHMT1	3.71e-05	84	248	7	CID000005701
Drug	IPSP	GABRQ CACNA1B CACNA1E MARCHF7 GRIK1 SBNO2 GABRA5	4.66e-05	87	248	7	CID000022083
Drug	L-BMAA	GRIA2 GRID1 GRIK1 GRIK2 SLC7A5	5.51e-05	38	248	5	CID000028558
Drug	4CPG	GCLC GRIA2 GRID1 GRIK1 SLC7A5	5.51e-05	38	248	5	CID000005115
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A	TUBG2 PHKG2 CPLANE1 MOCS1 MED16 ABHD2 DOCK9 ARHGAP35 EPN2 ARHGAP28	5.60e-05	194	248	10	4529_DN
Drug	Nifedipine [21829-25-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	CDK18 AADAC ATP6V1B1 ITGB7 ZFP36L2 MED16 DOCK9 ITIH5 RASGRP2 GABRA5	5.85e-05	195	248	10	6006_UP
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A	CUL9 ALS2CL FBXO22 ZFP36L2 ANKRD26 NR1D1 SBNO2 MMP25 SLC7A5 RASGRP2	5.85e-05	195	248	10	6174_DN
Drug	LY 294002; Up 200; 10uM; HL60; HT_HG-U133A	ZCCHC24 BNC2 TMEM94 ALS2CL ITGB7 TINF2 ABHD2 SLC9A5 SLC33A1 RASGRP2	6.10e-05	196	248	10	1168_UP
Drug	staurosporine; Down 200; 0.01uM; MCF7; HG-U133A	ZMYM2 GABRQ EPX ZZEF1 NUAK1 ARMH3 MCHR1 SBNO2 RASGRP1 EHMT1	6.10e-05	196	248	10	425_DN
Drug	2-amino-4-phosphonobutyric acid	ADCY2 TACR3 CACNA1B CACNA1E GRIA2 GRID1 GRIK1	6.22e-05	91	248	7	CID000002207
Drug	AP-7	GABRQ MOV10L1 GRIA2 GRID1 GRIK1 GABRA5	6.36e-05	63	248	6	CID000003122
Drug	Cyclacillin [3485-14-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	ADCY2 NRP1 ZBTB7A ZFP36L2 PLXNA3 MED16 LAMA2 NR1D1 SLC9A5 PCM1	6.37e-05	197	248	10	3800_DN
Drug	Chlormezanone [80-77-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A	ZCCHC24 CUL9 ANKMY1 DOCK5 ZFP36L2 MED16 ARHGAP35 MMP25 PCM1 RASGRP2	6.37e-05	197	248	10	3235_DN
Drug	N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; PC3; HT_HG-U133A	EFS TRPC6 FBXO22 TPP1 COL14A1 ARHGAP35 CRHR2 RIF1 PCM1 GABRA5	6.37e-05	197	248	10	4622_UP
Drug	Riluzole hydrochloride; Up 200; 14.8uM; PC3; HT_HG-U133A	RAPGEF5 SCEL SLC22A7 NRP1 ZBTB7A ZFP36L2 GALR3 STXBP5L RIF1 ARHGAP28	6.37e-05	197	248	10	3666_UP
Drug	Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A	ZMYM2 ZBTB7A MIA2 ZFP36L2 KCNJ3 PRR14L ZBTB33 ANKRD26 ARHGAP35 LNPEP	6.64e-05	198	248	10	2256_DN
Drug	Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ZBTB7A CABYR PRR14L C5 MOCS1 ANKRD26 ARHGAP35 NR1D1 EPN2 PCM1	6.64e-05	198	248	10	2217_DN
Drug	Chlormezanone [80-77-3]; Down 200; 14.6uM; PC3; HT_HG-U133A	TUBG2 ZMYM2 ANKMY1 ACE SLC22A7 TLN2 PRR14L ANKRD26 DUOX2 GRIK2	6.64e-05	198	248	10	4636_DN
Drug	HCBP-Gly	ACE MME ANPEP	6.87e-05	8	248	3	CID000124786
Drug	BTDS	GABRQ GRIK1 SLC7A5	6.87e-05	8	248	3	CID003034022
Drug	Methazolamide [554-57-4]; Up 200; 17uM; PC3; HT_HG-U133A	ITGB7 ZFP36L2 KCNJ3 TPP1 COL14A1 TLN2 CRHR2 MMP25 USP2 RIF1	6.93e-05	199	248	10	5794_UP
Drug	ng S	EFS EPX SLC22A7 BDNF SENP8	7.10e-05	40	248	5	CID000440235
Drug	dl-cystine	TRPC6 PRODH2 GCLC PKHD1 ANPEP DUOX2 LNPEP SLC7A5	8.22e-05	128	248	8	CID000000595
Drug	Sp(1-7)	TACR3 MME MARCHF7 SLC33A1	8.61e-05	22	248	4	CID000115322
Drug	colchine	ATP6V1B2 GABRQ EPX BDNF TUBG1 GHSR GCLC COL14A1 COL17A1 ANPEP ABCB5 LAMA2 MARCHF7 GABRA5	8.64e-05	383	248	14	CID000002833
Drug	5 beta-alphaxalone	GABRQ KCNJ3 FLII GRIK1 GABRA5	9.01e-05	42	248	5	CID000068930
Drug	ethylene dichloride	AADAC ALS2CL SLC22A7 SGPL1 SMG9 PDP2 COL14A1 MIGA1 ALAS2 MME TAF2 DDHD2 FHIP1A LDLRAD4 WIPI1 SRCIN1 USP2	9.51e-05	539	248	17	ctd:C024565
Drug	L-Glutamic Acid	BCAT1 GCLC GRIA2 GRID1 GRIK1 GRIK2	9.78e-05	68	248	6	DB00142
Drug	DCG-IV	BDNF KCNJ3 CACNA1B CACNA1E GRIA2 GRIK1	9.78e-05	68	248	6	CID000115114
Drug	NSC524461	ACE PDP2 MME ANPEP DSG2	1.01e-04	43	248	5	CID000352040
Drug	1m5b	GRIA2 GRIK1 GRIK2	1.02e-04	9	248	3	CID000447081
Drug	LY339434	GRIA2 GRIK1 GRIK2	1.02e-04	9	248	3	CID006324635
Drug	SP(3-11)	ACE TACR3 ANPEP	1.02e-04	9	248	3	CID003084968
Drug	felbamate	GABRQ GRIA2 GRID1 GRIK1 GRIK2 GABRA5	1.15e-04	70	248	6	CID000003331
Drug	Quisqualate	GRIA2 GRIK2	1.18e-04	2	248	2	DB02999
Drug	aristolactam AII	CACNA1B CACNA1E	1.18e-04	2	248	2	CID000148657
Drug	alkosin	CACNA1B CACNA1E	1.18e-04	2	248	2	CID005488638
Drug	Enkephalins	MME ANPEP	1.18e-04	2	248	2	ctd:D004745
Drug	Candoxatril	ACE MME	1.18e-04	2	248	2	DB00616
Drug	norcepharadione B	CACNA1B CACNA1E	1.18e-04	2	248	2	CID000189168
Drug	piperolactam A	CACNA1B CACNA1E	1.18e-04	2	248	2	CID003081016
Drug	5-phenylproline	ACE MME	1.18e-04	2	248	2	CID000409781
Drug	5-nitro-6,7,8,9-tetrahydrobenzo(G)indole-2,3-dione-3-oxime	GRIK1 GRIK2	1.18e-04	2	248	2	ctd:C084273
Drug	ivermectin	GABRQ CLCN5 COL14A1 VPS18 ABCB5 SRCIN1 GABRA5	1.20e-04	101	248	7	CID006435110
Drug	pD 8	BDNF GRIA2 GRIK1 CRHR2	1.23e-04	24	248	4	CID000656948
Drug	isoguvacine	GABRQ SNAP29 UTS2R GRIK1 GABRA5	1.26e-04	45	248	5	CID000003765
Drug	riluzole	GABRQ BDNF CACNA1B CACNA1E GRIA2 GRID1 GRIK1 GRIK2 GABRA5	1.28e-04	174	248	9	CID000005070
Drug	cyclothiazide	GABRQ BDNF GRIA2 GRID1 GRIK1 GRIK2 GABRA5	1.36e-04	103	248	7	CID000002910
Drug	Secobarbital	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB00418
Drug	Metharbital	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB00463
Drug	Pentobarbital	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB00312
Drug	Talbutal	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB00306
Drug	Butalbital	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB00241
Drug	Butabarbital	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB00237
Drug	Barbituric acid derivative	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB01496
Drug	Barbital	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB01483
Drug	Hexobarbital	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB01355
Drug	Aprobarbital	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB01352
Drug	Amobarbital	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB01351
Drug	Heptabarbital	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB01354
Drug	Butethal	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB01353
Drug	Methylphenobarbital	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB00849
Drug	Primidone	GRIA2 GRIK2 GABRA5	1.45e-04	10	248	3	DB00794
Drug	Benzoates	GRIA2 GRIK1 GRIK2	1.45e-04	10	248	3	ctd:D001565
Drug	UK 79300	ACE MME ANPEP EHMT1	1.45e-04	25	248	4	CID000122116
Drug	L-quisqualic acid	GABRQ ADCY2 BDNF TUBG1 GRIA2 GRID1 GRIK1 GRIK2 GABRA5	1.66e-04	180	248	9	CID000001209
Drug	Thiopental	GRIA2 GRIK2 GABRA5	1.97e-04	11	248	3	DB00599
Drug	Phenobarbital	GRIA2 GRIK2 GABRA5	1.97e-04	11	248	3	DB01174
Drug	Rb 104	ACE MME ANPEP	1.97e-04	11	248	3	CID000132708
Drug	Sch 39370	ACE TACR3 MME ANPEP	1.98e-04	27	248	4	CID000121872
Drug	Senktide	TACR3 MME FLII GRIK1	2.29e-04	28	248	4	CID000108147
Drug	Terfenadine [50679-08-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A	ZMYM2 XYLT2 ZBTB7A ZFP36L2 TMEM70 TLN2 PRR14L ABHD2 PCM1	2.58e-04	191	248	9	2227_DN
Drug	C-X6	BDNF GRIA2 GRIK1	2.61e-04	12	248	3	CID005288002
Drug	bc 264	MOV10L1 MME ANPEP	2.61e-04	12	248	3	CID005311016
Drug	Ala-phe	ACE TPP1 MME ANPEP	2.63e-04	29	248	4	CID000002080
Drug	H526	MYH6 ACE PDP2 TACR3 MME ANPEP DUOX2 LNPEP SLC33A1	2.68e-04	192	248	9	CID000002550
Drug	Gabapentin [60142-96-3]; Up 200; 23.4uM; MCF7; HT_HG-U133A	BRINP1 EPX ZZEF1 DOCK5 TPP1 MED16 MMP25 IRS2 PCM1	2.79e-04	193	248	9	7229_UP
Drug	Decamethonium bromide [541-22-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A	EFS ANKMY1 ZZEF1 ITGB7 COL14A1 DOCK9 CRHR2 ITIH5 MMP25	2.79e-04	193	248	9	4174_UP
Drug	Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A	RAPGEF5 EPX ZFP36L2 CCR7 CPLANE1 MOCS1 MED16 USP2 IRS2	2.79e-04	193	248	9	5271_UP
Drug	sodium	ATP6V1B1 ATP6V1B2 TRPC6 GABRQ ADCY2 BDNF GCLC KCNJ3 PDP2 EPN1 SLC4A9 SLC6A18 MCHR1 DUOX2 GRIA2 GRID1 GRIK1 SLC9A5 KCNT2 SLC7A5 SLC2A13 UEVLD GABRA5	2.82e-04	944	248	23	CID000000923
Drug	LY 294002; Up 200; 10uM; HL60; HT_HG-U133A	RALGAPA1 ZCCHC24 IQSEC1 TLN2 CCR7 ABHD2 ITIH5 CRB1 GABRA5	2.89e-04	194	248	9	6195_UP
Drug	Tridihexethyl chloride; Up 200; 11.4uM; MCF7; HT_HG-U133A	CDK18 CUL9 ALS2CL ZFP36L2 LDLRAD4 MED16 DOCK9 ARHGAP35 IKZF4	2.89e-04	194	248	9	3526_UP
Drug	Piromidic acid [19562-30-2]; Up 200; 13.8uM; PC3; HT_HG-U133A	CDK18 RAPGEF5 ADCY2 ZFP36L2 COL14A1 TLN2 EPN1 COL17A1 ARHGAP28	2.89e-04	194	248	9	4575_UP
Drug	Benzocaine [94-09-7]; Up 200; 24.2uM; PC3; HT_HG-U133A	EFS GABRQ ZZEF1 ZFP36L2 CCR4 MOCS1 CRHR2 USP2 GABRA5	2.89e-04	194	248	9	4224_UP
Drug	Fusaric acid [536-69-6]; Down 200; 22.4uM; MCF7; HT_HG-U133A	ANKMY1 CLCN5 ZFP36L2 MED16 ABHD2 EPN2 SIPA1L1 EHMT1 IRS2	2.89e-04	194	248	9	4105_DN
Drug	Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A	ANKMY1 TIPRL ALS2CL ZBTB7A ZFP36L2 MOCS1 MED16 ARHGAP35 EHMT1	2.89e-04	194	248	9	4107_DN
Drug	Haloperidol [52-86-8]; Up 200; 10.6uM; PC3; HT_HG-U133A	AADAC ZZEF1 ZFP36L2 TPP1 TLN2 ADGRF5 GALR3 DOCK9 ARHGAP35	2.89e-04	194	248	9	4678_UP
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; HL60; HT_HG-U133A	ZCCHC24 DOCK5 TINF2 ZFP36L2 ARMH3 MMP25 LNPEP PCM1 RASGRP2	3.01e-04	195	248	9	1184_UP
Drug	Fillalbin [4540-25-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A	EFS BRINP1 ITGB7 SLC22A7 NRP1 CABYR COL14A1 DOCK9 GABRA5	3.01e-04	195	248	9	4172_UP
Disease	Bipolar Disorder	ABCA13 RAPGEF5 ACE ADCY2 BDNF DNAH8 CACNA1B MCHR1 DOCK9 GRIA2 GRID1 GRIK1 GRIK2 NR1D1 CRHR2 RASGRP1 PBRM1 GABRA5	1.12e-07	477	244	18	C0005586
Disease	Schizophrenia	ABCA13 GABRQ ACE ALS2CL BDNF SNAP29 PRODH2 GCLC KCNJ3 TACR3 CACNA1B MCHR1 LAMA2 GRIA2 GRID1 GRIK1 GRIK2 XRCC1 SBNO2 PBRM1 PCM1 GABRA5	4.88e-06	883	244	22	C0036341
Disease	hepatitis A (is_implicated_in)	ACE XRCC1	6.81e-05	2	244	2	DOID:12549 (is_implicated_in)
Disease	leukocyte adhesion deficiency 3 (implicated_via_orthology)	FERMT3 RASGRP2	6.81e-05	2	244	2	DOID:0110912 (implicated_via_orthology)
Disease	complex cortical dysplasia with other brain malformations 4 (implicated_via_orthology)	TUBG2 TUBG1	6.81e-05	2	244	2	DOID:0090138 (implicated_via_orthology)
Disease	Pseudoxanthoma Elasticum, Incomplete	XYLT1 XYLT2	2.03e-04	3	244	2	C1867450
Disease	Pseudoxanthoma elasticum	XYLT1 XYLT2	2.03e-04	3	244	2	cv:C0033847
Disease	Autosomal recessive inherited pseudoxanthoma elasticum	XYLT1 XYLT2	2.03e-04	3	244	2	cv:C1275116
Disease	PSEUDOXANTHOMA ELASTICUM	XYLT1 XYLT2	2.03e-04	3	244	2	264800
Disease	familial hemiplegic migraine 1 (implicated_via_orthology)	CACNA1B CACNA1E	2.03e-04	3	244	2	DOID:0111181 (implicated_via_orthology)
Disease	Gronblad-Strandberg Syndrome	XYLT1 XYLT2	2.03e-04	3	244	2	C0376359
Disease	Ciliopathies	TTC8 PKHD1 CPLANE1 DNAH5 DNAH8 CRB1	3.14e-04	110	244	6	C4277690
Disease	Intellectual Disability	RALGAPA1 TMEM94 ZMYM2 BDNF PTCHD1 TPP1 IQSEC1 TAF2 CACNA1B CACNA1E GRIA2 ATL1	3.79e-04	447	244	12	C3714756
Disease	migraine (implicated_via_orthology)	CACNA1B CACNA1E	4.04e-04	4	244	2	DOID:6364 (implicated_via_orthology)
Disease	Pseudoxanthoma Elasticum	XYLT1 XYLT2	4.04e-04	4	244	2	C0033847
Disease	liver cirrhosis (is_implicated_in)	ACE PHKG2 C5 XRCC1	4.37e-04	43	244	4	DOID:5082 (is_implicated_in)
Disease	Cocaine-Related Disorders	BDNF TACR3 DNAH8 GRIA2 SRCIN1 CRHR2	4.38e-04	117	244	6	C0236736
Disease	Lung diseases	ACE DNAH5 EFEMP2 CRHR2 PRKDC	4.79e-04	78	244	5	C0024115
Disease	Prostatic Neoplasms	ACE CASZ1 NRP1 JAK1 ZBTB7A ZFP36L2 TPP1 MME EFEMP2 NOX3 CLDN7 XRCC1 CCNH PRKDC	6.68e-04	616	244	14	C0033578
Disease	Malignant neoplasm of prostate	ACE CASZ1 NRP1 JAK1 ZBTB7A ZFP36L2 TPP1 MME EFEMP2 NOX3 CLDN7 XRCC1 CCNH PRKDC	6.68e-04	616	244	14	C0376358
Disease	Atrial Septal Defects	MYH6 GABRQ	6.70e-04	5	244	2	C0018817
Disease	response to bevacizumab, Proteinuria	JAK1 DNAH5	6.70e-04	5	244	2	EFO_0005943, HP_0000093
Disease	follicular lymphoma (implicated_via_orthology)	ATP6V1B1 ATP6V1B2	6.70e-04	5	244	2	DOID:0050873 (implicated_via_orthology)
Disease	Cocaine Abuse	BDNF TACR3 DNAH8 GRIA2 SRCIN1 CRHR2	6.76e-04	127	244	6	C0009171
Disease	smoking status measurement	BNC2 PDE7A BRINP1 ADCY2 BDNF ELOVL7 XYLT1 KCNJ3 HECW2 PKHD1 DNAH8 GOLGA3 TFAP2D LAMA2 GRID1 GRIK1 GRIK2 IKZF4 LNPEP BSCL2 EXOC4	6.95e-04	1160	244	21	EFO_0006527
Disease	tea consumption measurement	TUBG2 CUL9 PKHD1 LAMA2 NOX3 GRID1	7.33e-04	129	244	6	EFO_0010091
Disease	Kidney Failure	TRPC6 ACE MME	7.66e-04	22	244	3	C0035078
Disease	Global developmental delay	TMEM94 IQSEC1 CACNA1B CACNA1E TRAPPC12 GABRA5	8.60e-04	133	244	6	C0557874
Disease	QRS duration, response to sulfonylurea	MDN1 LRRC63 DOCK9	8.75e-04	23	244	3	EFO_0005055, EFO_0007922
Disease	cardiovascular measurement	GRID1 TMEM232	9.99e-04	6	244	2	EFO_0004298
Disease	Cocaine Dependence	BDNF TACR3 DNAH8 GRIA2 SRCIN1 CRHR2	1.08e-03	139	244	6	C0600427
Disease	paracentral lobule volume measurement	STXBP5L DOCK9 GRIK2	1.12e-03	25	244	3	EFO_0010317
Disease	diet measurement	BNC2 NUP210L BCAT1 ST8SIA6 NALCN HECW2 PKHD1 ARMH3 DNAH5 FERMT3 FLT3 TFAP2D LAMA2 OR14J1 NOX3 GRID1 GRIK2 PRKDC EXOC4	1.24e-03	1049	244	19	EFO_0008111
Disease	tumor necrosis factor ligand superfamily member 6, soluble form measurement	RNF123 CELSR3	1.39e-03	7	244	2	EFO_0020797
Disease	Goiter	CLCN5 DUOX2	1.39e-03	7	244	2	C0018021
Disease	hereditary ataxia (implicated_via_orthology)	CACNA1B CACNA1E	1.39e-03	7	244	2	DOID:0050951 (implicated_via_orthology)
Disease	white matter microstructure measurement	BNC2 DOCK5 CCM2 NUAK1 SLC4A9 DOCK9 SGPP2 OR14J1 CRB1 SSH2	1.62e-03	390	244	10	EFO_0005674
Disease	creatinine measurement	CDK18 ATP6V1B1 CAND1 PDE7A FRMD7 DPYSL5 ADCY2 SLC22A7 CASZ1 FBXO22 ZFP36L2 PKHD1 WIPI1 LAMA2 INTS8 SBNO2 RNF123 CELSR3	1.68e-03	995	244	18	EFO_0004518
Disease	obstructive sleep apnea (biomarker_via_orthology)	ACE GHSR	1.85e-03	8	244	2	DOID:0050848 (biomarker_via_orthology)
Disease	renal tubular acidosis (implicated_via_orthology)	ATP6V1B1 ATP6V1B2	1.85e-03	8	244	2	DOID:14219 (implicated_via_orthology)
Disease	cystatin C measurement	BNC2 PDE7A ZBTB7A FBXO22 PKHD1 FLT3 TFAP2D SENP8 CRB1 RNF123	2.02e-03	402	244	10	EFO_0004617
Disease	urate measurement, bone density	ATP6V1B1 TRPC6 TM9SF3 CASZ1 DOCK5 MOV10L1 DNAH8 LDLRAD4 ABCB5 MARCHF7 GRID1 ATL1 PRKDC	2.08e-03	619	244	13	EFO_0003923, EFO_0004531
Disease	smoking behavior	BRINP1 BDNF KCNJ3 PKHD1 GOLGA3 LAMA2 GRID1 IKZF4 EXOC4	2.26e-03	341	244	9	EFO_0004318
Disease	Alcohol abuse	BDNF GHSR TACR3 GALR3	2.33e-03	67	244	4	C0085762
Disease	Seizures	BDNF TMEM70 CACNA1B CACNA1E GRIA2 GRIK1 GABRA5	2.34e-03	218	244	7	C0036572
Disease	pseudoxanthoma elasticum (is_implicated_in)	XYLT1 XYLT2	2.36e-03	9	244	2	DOID:2738 (is_implicated_in)
Disease	Malignant Glioma	DMXL1 CLCN5 CCR4 XRCC1	2.73e-03	70	244	4	C0555198
Disease	anorexia nervosa	SGPP2 GRID1 CRB1 CELSR3	2.73e-03	70	244	4	MONDO_0005351
Disease	mixed gliomas	DMXL1 CLCN5 CCR4 XRCC1	2.73e-03	70	244	4	C0259783
Disease	Mood Disorders	BDNF MCHR1 GRIK2 CRHR2 BSCL2 GABRA5	2.82e-03	168	244	6	C0525045
Disease	response to trastuzumab, methylcobalamin deficiency type cblE, left ventricular diastolic function measurement	TRPC6 BRINP1	2.93e-03	10	244	2	EFO_0008204, EFO_0008347, MONDO_0009354
Disease	myelodysplastic syndrome	TAF2 GRID1	2.93e-03	10	244	2	EFO_0000198
Disease	stromal interaction molecule 1 measurement	MED16 IGHV1-69	2.93e-03	10	244	2	EFO_0802093
Disease	Muscular dystrophy, limb-girdle, autosomal dominant	MYH6 TNPO3	2.93e-03	10	244	2	cv:C5675009
Disease	intelligence, self reported educational attainment	KCNJ3 ARMH3 IKZF4 CELSR3 EXOC4	2.93e-03	117	244	5	EFO_0004337, EFO_0004784
Disease	complement C1q tumor necrosis factor-related protein 5 measurement	USP2 LNPEP	3.57e-03	11	244	2	EFO_0801494
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	ACE PKHD1	3.57e-03	11	244	2	DOID:0110861 (biomarker_via_orthology)
Disease	hemopexin measurement	CRB1 KCNT2	3.57e-03	11	244	2	EFO_0008149
Disease	obstructive sleep apnea (is_implicated_in)	ACE BDNF	3.57e-03	11	244	2	DOID:0050848 (is_implicated_in)
Disease	placenta growth factor measurement	RAPGEF5 NRP1	3.57e-03	11	244	2	EFO_0010626
Disease	neuroimaging measurement	EFS DPYSL5 NRP1 JAK1 CCM2 ST8SIA6 NUAK1 PKHD1 TLN2 SLC4A9 DOCK9 LAMA2 FRYL ARHGAP35 ITIH5 SSH2 LINC02915 EXOC4	3.60e-03	1069	244	18	EFO_0004346
Disease	household income	BRINP1 ELOVL7 KCNJ3 ARMH3 NOX3 IKZF4 RNF123 EXOC4	3.97e-03	304	244	8	EFO_0009695
Disease	Manic	ADCY2 BDNF DNAH8 GRIK2	4.03e-03	78	244	4	C0338831
Disease	diastolic blood pressure, systolic blood pressure	BNC2 MYH6 CASZ1 XYLT1 DOCK5 SMG9 TLN2 TAF2 OR14J1 GSX2 CRB1 RASGRP1 PCM1	4.06e-03	670	244	13	EFO_0006335, EFO_0006336
Disease	cortical surface area measurement	BNC2 EFS OR5B12 RAPGEF5 DPYSL5 CUL9 ELOVL7 NRP1 SNAP29 NUAK1 PKHD1 TLN2 CCR4 DOCK9 LAMA2 MARCHF7 FRYL ITIH5 ARHGAP28 SSH2 LINC02915	4.12e-03	1345	244	21	EFO_0010736
Disease	sleep apnea	BNC2 BDNF ISL2	4.40e-03	40	244	3	EFO_0003877
Disease	spondylosis	XYLT1 IQSEC1 ARHGAP35	4.40e-03	40	244	3	MONDO_0002253
Disease	male infertility (implicated_via_orthology)	CABYR BSCL2	5.00e-03	13	244	2	DOID:12336 (implicated_via_orthology)
Disease	intermediate coronary syndrome (is_marker_for)	ACE BDNF	5.00e-03	13	244	2	DOID:8805 (is_marker_for)
Disease	beta-nerve growth factor measurement	ST8SIA6 TLN2 MIGA1	5.05e-03	42	244	3	EFO_0008035
Disease	Autism Spectrum Disorders	GABRQ BDNF PTCHD1 GABRA5	5.47e-03	85	244	4	C1510586
Disease	chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology)	SNAP29 PRODH2	5.80e-03	14	244	2	DOID:0060413 (implicated_via_orthology)
Disease	insulin metabolic clearance rate measurement, glucose homeostasis measurement	ZZEF1 ST8SIA6	5.80e-03	14	244	2	EFO_0006830, EFO_0006896
Disease	Glioma	DMXL1 CLCN5 CCR4 XRCC1	5.94e-03	87	244	4	C0017638
Disease	Colorectal Carcinoma	EFS ABCA13 BRINP1 CABYR ZFP36L2 PKHD1 DNAH8 VPS18 ABCB5 GRID1 XRCC1 SLC33A1 EXOC4	5.95e-03	702	244	13	C0009402
Disease	matrix metalloproteinase 1 measurement	NT5DC4 MMP25	6.66e-03	15	244	2	EFO_0010588
Disease	Situs ambiguus	PKD1L1 DNAH5	6.66e-03	15	244	2	C0266642
Disease	Alcoholic Intoxication, Chronic	ACE BDNF GHSR TACR3 GALR3 GRIK1 GABRA5	7.17e-03	268	244	7	C0001973
Disease	thyroglobulin measurement	OR5B12 GABRA5	7.57e-03	16	244	2	EFO_0010050
Disease	pneumonia (is_implicated_in)	ACE C5	7.57e-03	16	244	2	DOID:552 (is_implicated_in)
Disease	Seasonal Affective Disorder	OPN4 NR1D1	7.57e-03	16	244	2	C0085159
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	ACE PKHD1	7.57e-03	16	244	2	DOID:0110861 (implicated_via_orthology)
Disease	complement factor H-related protein 4 measurement	SGPP2 CRB1 KCNT2	7.78e-03	49	244	3	EFO_0600091
Disease	mean fractional anisotropy measurement	ZZEF1 DOCK5 NUAK1 SLC4A9	8.07e-03	95	244	4	EFO_0008399
Disease	Tourette syndrome	XYLT1 FLT3 SGPP2	8.22e-03	50	244	3	EFO_0004895

Protein segments in the cluster

Peptide	Gene	Start	Entry
ALTMLSRENVGYAST	SLC33A1	201	O00400
DSLYEGTFTRDLTLM	ALS2CL	526	Q60I27
DYAELSSRILSYMSS	COL17A1	1126	Q9UMD9
ASYSSQTMLLRDARS	ERICH6B	216	Q5W0A0
YVSATVISLAHMDSL	SLC4A9	776	Q96Q91
MSLYNSLETATSTEE	CCDC117	261	Q8IWD4
DTFSNLLYVRSMKSE	CDC23	301	Q9UJX2
ISTYSTIDAKMASSR	AGAP9	121	Q5VTM2
ASRAGITMESYLSES	CCNH	221	P51946
DADLYTSRVMLSSQV	BDNF	86	P23560
VSERYLTMDDLTTAL	BCAT1	306	P54687
MLFAELTYTLATEEA	COPS6	181	Q7L5N1
VIMDNFEYLTRDSSI	CACNA1E	1721	Q15878
FYSSSSVMLLLLDIR	BRINP1	686	O60477
DLTNILASSRSYAML	ACE	171	P12821
SEYFTTDRSLEKAML	AADAC	251	P22760
DYMVLDLSTTSSLQS	BNC2	956	Q6ZN30
ASSLRDYAASTMTEF	CASZ1	171	Q86V15
LLSSLLLYESKSRMS	CDK18	401	Q07002
LSRLYTATSLMQIDD	ABHD2	291	P08910
RMVISLTSKELSAYS	ABCB5	226	Q2M3G0
RLTTSLRITYMTDSC	ARMH1	61	Q6PIY5
QRVLTTDYALLMEST	GRIK1	741	P39086
LISRDEITAYFMRAS	RASGRP1	516	O95267
MDLINSTDYLINAST	GPR33	1	Q49SQ1
TMTDTYLLNLAVADI	CCR7	91	P32248
YNSTLTLAEALLSME	CFAP46	1676	Q8IYW2
LMSRIFSSSDVAFIS	ABCA13	4556	Q86UQ4
SFDNLYSMVLRLSTN	ARMH3	561	Q5T2E6
SVYMEAEATALLSDT	CABYR	376	O75952
RSMTDVYLLNLAISD	CCR4	71	P51679
ASVLRMLSSFLSEDV	ANPEP	481	P15144
LSASATELLQDYMLT	CCM2	291	Q9BSQ5
ESMNLTAYDLSVDTL	AMPD2	461	Q01433
EYLSRGLMVSLSTDD	AMPD2	751	Q01433
SMSEASLEVTSRYRI	ANKRD26	1236	Q9UPS8
VIMDNFEYLTRDSSI	CACNA1B	1706	Q00975
SRLTLFSEMVYSQEL	DMXL1	941	Q9Y485
MDAATLTYDTLRFAE	ATG4B	1	Q9Y4P1
STFQTVLSEMLNYLE	TFAP2D	396	Q7Z6R9
MTEYLNFEKSSSVSR	ESRP1	161	Q6NXG1
ATSQSYSRCLELMLT	PRODH2	406	Q9UF12
ESTLGIMYRSELLSF	INTS8	746	Q75QN2
YGAEIFETSMLLISS	JAK1	281	P23458
SVISIYVSESMDRSS	DSG2	391	Q14126
ESRSSLTASMYEYTL	HECW2	56	Q9P2P5
TVLYMADSETFISLE	FBXO22	101	Q8NEZ5
EMIASTAYLELFLRS	FHIP1B	346	Q8N612
SQLSQETVRVLMSYA	MMP25	131	Q9NPA2
RLSAITMALQYGSES	PBRM1	341	Q86U86
STAYMELSSLRSEDT	IGHV1-58	96	A0A0C4DH39
MLSITYHSSIRSLEV	KIAA0100	646	Q14667
SYSDLVLFFLTMSLA	MDN1	4616	Q9NU22
LAEDILNTMFDTSYS	FLII	1116	Q13045
MDTSASTAYLQISSL	IGHV7-81	91	A0A0B4J1V7
STAYLQISSLKAEDM	IGHV7-81	96	A0A0B4J1V7
DMIYFSSDAVTSRVL	MOV10L1	56	Q9BXT6
SREEMVSYFLRSSSV	RASGRP2	476	Q7LDG7
MTEFSVKSTIISRYA	ITIH5	51	Q86UX2
MESRKLISATDIQYS	ZBTB33	1	Q86T24
VVDSDYTQFALMLSR	LCN12	121	Q6JVE5
RVTITADKSTSTAYM	IGHV1-69	86	P01742
STAYMELSSLRSEDT	IGHV1-69	96	P01742
SSSLMTEIADLTYNV	EPN2	36	O95208
YDSSAARVTIGLTSM	GABRQ	291	Q9UN88
LEESMLYSISRDSDI	GINM1	171	Q9NU53
QLESTFDMKRYLSSS	HMX3	241	A6NHT5
RDTSTSTVYMELSSL	IGHV1-46	91	P01743
STVYMELSSLRSEDT	IGHV1-46	96	P01743
STAYMELSSLRSEDT	IGHV1-45	96	A0A0A0MS14
RKLDEMTASYSDVTL	IQSEC1	291	Q6DN90
LMDQSTAERYVASES	FRMD7	636	Q6ZUT3
TAASVSFMFSYILLT	DUOX2	1086	Q9NRD8
ELSKNDSMSTTRTYI	CAND1	221	Q86VP6
DTAYMELSSLRSEDT	IGHV1-24	96	A0A0C4DH33
RNTSISTAYMELSSL	IGHV1-8	91	P0DP01
STAYMELSSLRSEDT	IGHV1-8	96	P0DP01
SYTANLAAFLTVERM	GRIA2	636	P42262
MSRSFYVDSLIIKDT	GSX2	1	Q9BZM3
SMFEALRDTIYSEVA	PCM1	1376	Q15154
SLTMVALQSRLDYAT	PLXNA3	1366	P51805
ASSEVAILTVMSYDR	OR14J1	106	Q9UGF5
ASMVYGSEVSLSLRL	EPX	311	P11678
ISYDSSDQTALYIRM	PDE7A	51	Q13946
YNTSERMTSLFIKVT	DNAH8	276	Q96JB1
AADSSRSIYEVAMQL	FRYL	1216	O94915
NSTELAAEEYTLMSI	GCLC	506	P48506
IMDLVSSLSRTYKES	MME	376	P08473
MTKLRASTTSETIQY	CRHR2	291	Q13324
DTVASEMNRIYTLFL	DDHD2	321	O94830
RSALKDTYMLSSTVS	PGM2	366	Q96G03
DTYMLSSTVSSKILR	PGM2	371	Q96G03
LTNLAYFTTLSTEQM	SLC7A5	291	Q01650
YFTTLSTEQMLSSEA	SLC7A5	296	Q01650
ETLLYDSNTSSMADR	LNPEP	441	Q9UIQ6
EDDGTLLYTMRLTIS	GABRA5	156	P31644
FSSSALLMYLATRDL	LAMA2	2371	P24043
RDMSTTTAYTDLSSL	IGHV1-38-4	91	P0DTW3
ALSTMVQLYSRTQDV	LCN15	131	Q6UWW0
AATRYETITAMTNLA	LRRC63	301	Q05C16
RVFSISMLDTLLYQS	KCNT2	886	Q6UVM3
QAMTELSQTLTTDYR	PRDM10	901	Q9NQV6
DTAYMELSSLRSEDT	IGHV1-69-2	96	A0A0G2JMI3
ITAESFLLASMAYDR	OR5B12	106	Q96R08
RDTSISTAYMELSRL	IGHV1-2	91	P23083
STAYMELSRLRSDDT	IGHV1-2	96	P23083
ASTLAMTKEYSFLRT	GOLGA3	201	Q08378
RVTITRDTSASTAYM	IGHV1-3	86	A0A0C4DH29
RDTSASTAYMELSSL	IGHV1-3	91	A0A0C4DH29
STAYMELSSLRSEDT	IGHV1-3	96	A0A0C4DH29
STAYMELSSLRSEDT	IGHV1-69D	96	A0A0B4J2H0
ITLIDSYESSSFMFL	PHKG2	91	P15735
ETTYVSNLTRSMSLV	GPN1	216	Q9HCN4
SNLTRSMSLVLDEFY	GPN1	221	Q9HCN4
SMSLVLDEFYSSLRV	GPN1	226	Q9HCN4
ASTRDLVDMVRSYAA	ALAS2	401	P22557
TDTSTSTAYMELRSL	IGHV1-18	91	A0A0C4DH31
STAYMELRSLRSDDT	IGHV1-18	96	A0A0C4DH31
MEALTSAAVAALTLY	MOCS1	591	Q9NZB8
LIMDAYNSLSSTVTL	ITGB7	381	P26010
RLSLQTMAVFYSSAA	MED16	396	Q9Y2X0
IRSSSGILSMVFYTD	NRP1	236	O14786
SSMITLTAIALDRYL	OPN4	156	Q9UHM6
MTLGNSTEVTEFYLL	OR5AK2	1	Q8NH90
SSASLDEYTLMRATF	IRS2	591	Q9Y4H2
KDQTVMFLSRTTYSL	NR1D1	491	P20393
NAIMTYLFSISEAEA	NT5DC4	226	Q86YG4
SIEEALMYSFQRLDS	PDP2	226	Q9P2J9
LMYSFQRLDSDISLE	PDP2	231	Q9P2J9
STYSTNRTMIRILFA	FLT3	301	P36888
MYASSFTLAAVSVDR	GALR3	106	O60755
LLTEYLDMKNTRTAS	EXOC4	396	Q96A65
LKTYFVNTEMSRSLS	ADCY2	1071	Q08462
EVMTTTAYLDLFLRS	FHIP1A	331	Q05DH4
LYNESASTMEILAVL	HEATR5A	1381	Q86XA9
SSQLYRESATTMEKL	HEATR5B	1406	Q9P2D3
TLRDSATVFALSTMI	ATL1	156	Q8WXF7
YIMSSTLRRLSITSV	DOCK5	1661	Q9H7D0
SSIRTEASQLLYFLM	DOCK9	1491	Q9BZ29
DGYMVTTLRFLDSLS	CPLANE1	416	Q9H799
FRELRTTTNLYLSSM	GHSR	71	Q92847
TTTNLYLSSMAFSDL	GHSR	76	Q92847
MAFSDLTSRTVHLYD	ELOVL7	1	A1L3X0
RSMSLYLSNKDTEFI	COG3	766	Q96JB2
ASDLLLYDVTENSMR	COL14A1	446	Q05707
LVLSEYASTEMSLHA	ATG9A	696	Q7Z3C6
RMVETTAYALLTSLN	C5	1246	P01031
SLDIKSVSYSASMAA	DUSP16	401	Q9BY84
YTRMSTSELISELFN	CLCN5	446	P51795
AIENILSFMSYDEIS	FBXO28	71	Q9NVF7
KSMDAIRSLASVSYA	DDX50	526	Q9BQ39
TLESSTLMEKYNTRI	CCDC183	471	Q5T5S1
ILSSSFMDTNLESLY	ANKMY1	366	Q9P2S6
MAIATSTQLARALYD	EFS	1	O43281
SLSYRTISCINAMLT	ECM2	321	O94769
LERRTDSSISNLMDY	MARCHF7	146	Q9H992
QFTSTYILTAMAIDR	MCHR1	196	Q99705
SSSLMSEIADLTYNV	EPN1	36	Q9Y6I3
TSLFTTMKTEELNRY	GRID1	206	Q9ULK0
RQLTLLVASEDSSYM	CUL9	1216	Q8IWT3
SLMSSEYESRSYTLE	CCDC168	2131	Q8NDH2
VSSLVAMYSTALLSL	GPR146	111	Q96CH1
VYSLAALMNSRSLEL	CELSR3	361	Q9NYQ7
ESYGDTISLSMFVRT	CRB1	731	P82279
VSELLDTYMSTLTSN	EXOC3	376	O60645
QRVLTSDYAFLMEST	GRIK2	726	Q13002
NSLMSYRASSVLRLT	EFEMP2	421	O95967
YRSDLLQMLDTLVFS	BSCL2	151	Q96G97
ASVSYVMFAITRTLT	SLC22A7	191	Q9Y694
STGYMEVSLDSLDLR	EHMT1	476	Q9H9B1
LSDSYDQFLVMLRVS	PKD1L1	856	Q8TDX9
MSDYISAIIELSALS	CYP4F22	226	Q6NT55
SRSLSANSIKVEMYS	IKZF4	91	Q9H2S9
TLTRSYNTSNLMEDL	DNAH5	2981	Q8TE73
RLDTNTSTYLMSLLA	DPYSL5	301	Q9BPU6
EVVVNASSRLMLSYD	NUP210L	1551	Q5VU65
YSLESIKMTFIDLSN	PRR14L	1691	Q5THK1
FSSSDLVMRARDSVY	ISL2	96	Q96A47
KSSYSLSDMVSNIEL	MIA2	516	Q96PC5
TDSYLLASMAIDRLV	OR1L4	111	Q8NGR5
NTDSYLLASMAIDRL	OR1L6	146	Q8NGR2
FFLSMLASSETVYTL	OR10J5	61	Q8NHC4
ASAELAFLTVMSYDR	OR14I1	106	A6ND48
VRYSSTETLAEDLMQ	MIGA1	576	Q8NAN2
SENVEYTLRSLSSLM	SLC2A13	6	Q96QE2
SRSMDSVLTLSDYDL	ARHGAP20	611	Q9P2F6
ILTDMSSYAEALREV	ATP6V1B2	296	P21281
LTDMSSYAEALREVS	ATP6V1B1	291	P15313
YSSMVIRDLTLRSAA	RFX1	856	P22670
AVYADSMLSFSLTTA	PTCHD1	366	Q96NR3
QTDAYLTLTSRMTGE	RIF1	26	Q5UIP0
VAAYASMSIFSTNLL	TAF2	316	Q6P1X5
MFYRRLSNLTSSEEV	FASTKD3	101	Q14CZ7
AMVASSSSLEKSYEL	POTEJ	891	P0CG39
TDLSLYRFLQTAEMV	SMG9	326	Q9H0W8
TAASTSRSLALMYES	SNAP29	56	O95721
LLDDFLLTYTVFMTT	RAPGEF5	101	Q92565
DIYVTVSSMALARSQ	SIPA1L1	1131	O43166
VTAYRLSTGLMITSV	ST8SIA6	316	P61647
YLTAEMASLSAILAV	SLC9A5	291	Q14940
VMADVSSSSYLQIVR	SBNO2	1181	Q9Y2G9
TSLTSAYSTRMILLT	MT-ND5	416	P03915
SFSLLTDMDDVTQVY	NUAK1	636	O60285
YDLTMTDSRNKTTTV	PKHD1	2586	P08F94
YFTGLSMLSAISTER	MRGPRX4	106	Q96LA9
KLMATLFSSYATADT	MYH6	616	P13533
ITAVFASIYSMTAIA	TACR3	166	P29371
DMISSSSIVLTSYIF	OR8U3	206	Q8NH85
LIMTSSTEFIRQASY	NOX3	186	Q9HBY0
TMDALTATRTYQTII	ARHGAP35	1411	Q9NRY4
TMAYSLNSSAQERLI	ERRFI1	51	Q9UJM3
TVLLSMGTIDLYRSS	STXBP5L	671	Q9Y2K9
NRMTSLYASIAVFSV	SLC6A18	296	Q96N87
NMVAELSSVFLDSLY	SGPL1	536	O95470
TAIAFTLLISTMDRY	SGPP2	171	Q8IWX5
YAMVVVLSRASRSLS	ACADVL	576	P49748
SYLENLQSDSSIVTM	ADGRF5	886	Q8IZF2
TVSSYSLQRQSLLDM	CDCA4	26	Q9BXL8
RYVKLISMETSSSSD	CDCA7	21	Q9BWT1
MYDSVLALSAALQAT	CLDN7	66	O95471
LYIALSEMTFREQTS	LINC02915	66	Q8N8G6
DEYMSRQLTSTVSVK	XIRP2	1901	A4UGR9
IMSTASVEIDDALYS	UBA6	31	A0AVT1
SLLSTYLQSMRDLLE	XYLT1	396	Q86Y38
QYDMTLTSFERALSL	TTC8	401	Q8TAM2
MISYAASSETLSVKR	TAS1R1	166	Q7RTX1
TEASSYEMDKRLVVS	RALGAPA1	1376	Q6GYQ0
VSRSASTVIAYAMKE	SSH2	396	Q76I76
LSYASAESLETMSEA	SRCIN1	136	Q9C0H9
LVSTIMSASTTTLRY	TUBG1	231	P23258
ESVLFNLTTMYELES	TRAPPC12	691	Q8WVT3
LSSYTEAVSSQEMLR	TMEM94	366	Q12767
RTTTQMELLYADSSE	KIF21A	1156	Q7Z4S6
ILSLLEYFSSKMSEN	TMEM232	411	C9JQI7
LREYTSRESKISSLM	TIPRL	211	O75663
TDIRDSLMQALASYV	RNF123	916	Q5XPI4
IYTADLAMGTRAAST	TINF2	311	Q9BSI4
LSFEVSYSEMVTEAL	ARHGAP28	286	Q9P2N2
RAKSLESLIYMSTRT	SCEL	286	O95171
MASILDEYENSLSRS	VPS18	1	Q9P253
SYSAVMELTRQLQIS	SOGA1	826	O94964
ISREYNELLMAISDS	EXT2	126	Q93063
LIIDSLGIQMTSSYA	PIGH	91	Q14442
LSYMDSLLRQSDVSL	SENP8	6	Q96LD8
MADSSYTSEVQAILA	FERMT3	461	Q86UX7
TLLSAMSEEQLSRYE	nan	96	A6NLC8
DMIRDLLRLSTSSYS	PSME4	966	Q14997
SSLSYLADSTLSEEM	PRKDC	2026	P78527
EDLAFYSSTVVSLLM	TNPO3	171	Q9Y5L0
YTSTSLDRNTLENML	ZMYM2	1341	Q9UBW7
LYRDVMLETYSSLVS	ZNF717	46	Q9BY31
DLYTERGSMLSTAIF	TM9SF3	316	Q9HD45
ASIFTLTVMSSERYA	UTS2R	136	Q9UKP6
MYSLSSSDEARQVDL	UEVLD	141	Q8IX04
EQDYEVLLVTSSFMS	XRCC1	81	P18887
DTQYDASSLILSMAS	ZZEF1	501	O43149
KTMLESSSYLIRTAR	TLN2	1606	Q9Y4G6
YQTMSLADATVITFS	SLC35G1	151	Q2M3R5
LVSTIMSASTTTLRY	TUBG2	231	Q9NRH3
YMFSDRSTSLSIEEE	TRPC6	86	Q9Y210
RYVTISSLVFSMDSQ	WIPI1	231	Q5MNZ9
SALLVTASYDTNVIM	WSB2	251	Q9NYS7
AITYNAMLAETSTVF	TMEM70	181	Q9BUB7
MSQLSSTLKRYTESA	USP2	1	O75604
MSSSQVRTSDAYLLF	USP2	581	O75604
MSTTLLSAFYDVDFL	ZFP36L2	1	P47974
ALAVAAFTVSVMRYS	TMEM163	101	Q8TC26
YLLMSASQTKSESVE	ZFYVE26	1036	Q68DK2
SDVMLTAYTAFARLS	XYLT2	551	Q9H1B5
ETVLASAYTGRLSMA	ZBTB22	106	O15209
TALMDFAYTATLTVS	ZBTB7A	86	O95365
SSAYSIESVIMQISA	UBE2Q1	361	Q7Z7E8
SLSSAYIQRVNTELM	TPP1	331	O14773
FVSMIASRSYLAESL	TMPPE	21	Q6ZT21
MSLLSAIDTSAASVY	ZCCHC24	1	Q8N2G6
LLRMSSTTSEKAYSL	KCNJ3	416	P48549
RTIFDSDLIDIAMYS	LDLRAD4	211	O15165
TFTLDTLLMFLYTAE	NALCN	71	Q8IZF0
DSLDYMTTTRKIYSS	MXRA5	1291	Q9NR99